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ABSTRACT

Electrostatics plays an essential role in molecular biology. Modeling
electrostatics in molecular biology is a complicated task due to the water phase,
mobile ions, and irregularly shaped inhomogeneous biological macromolecules. A
particular approach to calculating electrostatics in such a system is to apply the
Poisson-Boltzmann equation (PBE). This dissertation presents the popular DelPhi
package that solves PBE using a finite-difference method and delivers the
electrostatic potential distribution throughout the modeling box. Details descriptions
of some of the examples DelPhi can handle, and their accuracy with the analytical
solutions are presented. Receptor–ligand interactions are involved in various
biological processes; therefore, understanding the binding mechanism and ability to
predict the compulsory mode is essential for many biological investigations. So, this
dissertation also presents the use of electrostatics for the proper orientation guidance
and the pulling force to deliver the ligand close to the receptor. We use the newly
developed DelPhiForce steered Molecular Dynamics (DFMD) approach to model the
binding of barstar to barnase and demonstrate that the first-principles method can also
model the binding. It shows DFMD can successfully dock barnstar to barnase even if
both initial positions and orientations are entirely different from the correct one.
Single nucleotide polymorphism (SNP) is a single nucleotide variation in the
genome. Change of single amino acid in the corresponding protein due to these
variations results in single amino acid variation (SAV). SAVs cause intense
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alterations of the related biological processes and thus can be associated with many
human diseases. This dissertation reflects the use of existing computational
approaches to model the effects of SAVs to reveal molecular mechanisms related to
human diseases. We use our supervised in-house combinatory in-silico predictor
method to investigate the impact of unclassified missense mutations in the MEN1
gene found in breast cancer tissue issues. We also examine the biophysical and
biochemical properties to predict the effects of these missense variants on the menin
protein stability and interactions. The results are compared with the impact of known
pathogenic mutations in menin causing neoplasia. Together with our in-silico
consensus predictor, we classify missense mutations in menin protein found in breast
cancer tissue into pathogenic and benign, thus, suggesting an indicator for early
detection of elevated breast cancer risk.
In the end, we show the role of intravesicular pH in melanosome maturation
and formation. Here, we computationally investigate the pH-dependent stability of
several membrane proteins and compare them to the pH dependence of the strength
of TYR. We confirm that the pH optimum of TYR is neutral, and we also find that
proteins that are negative regulators of melanosomal pH are predicted to function
optimally at neutral pH. In contrast, positive pH regulators were expected to have an
acidic pH optimum. Our findings are consistent with previous work that demonstrated
a correlation between the pH optima of stability and activity. They are compatible
with the expected activity of positive and negative regulators of melanosomal pH.
Furthermore, our data suggest that disease-causing variants impact the pH
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dependence of melanosomal proteins; this is particularly prominent for the OCA2
protein. In conclusion, melanosomal pH appears to affect the activity of multiple
melanosomal proteins.
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CHAPTER ONE
INTRODUCTION

This chapter covers the introduction to the fundamental ideas and tools that are important
for the foundation of the work presented in this dissertation. It discusses the role of electrostatics
in molecular biology, including protein stability and protein-protein interactions. The other
sections of this chapter introduce Single Nucleotide Polymorphisms (SNPs) and their association
Zwith different diseases highlighting their effects on proteins functions. In the end, it describes
the role of pH on protein stability and activity.

1.1 Role of Electrostatics in Molecular Biology

Electrostatics is an essential component in the various biological process because each
atom of biomolecules carries a charge and thus the electrostatic interactions are present at atomic
levels of detail[1]. Electrostatic interactions dominate other forces when atoms or molecules are
apart at a longer distance than the typical bond length. They facilitate molecular recognition, and
biological activities of the biomolecules. For example, electrostatic forces participate in protein
folding and binding, protein -DNA/RNA interactions, ion binding, dimerization, and proteinmicrotubule binding[2]. Electrostatics is also responsible for the pH dependence on the stability
of biomolecules. Electrostatics is the major component of total

solvation energy of

biomolecules[3]. Furthermore, electrostatics is associated with the disease since disease-causing
mutants frequently alter wild-type interactions [4].
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1.2 Single Nucleotide Polymorphisms (SNPs)

Mutation is a change in the nucleotide sequence of DNA, which occurs during its
replication, recombination, or other processes. The mutation results in substitution, deletion, or
insertion. Many mutations are repaired before protein synthesis occurs, so they do not affect the
function of the corresponding biomolecules. Some of the mutations positively affect the related
organism, called beneficial mutations. However, other mutations may drastically reduce the
organism's ability to survive, and such mutations are called harmful mutations[5]. The single
nucleotide variation in the genome resulting in single amino acid variation is known as Single
Nucleotide Polymorphisms (SNPs)[6, 7]. They can change the corresponding biological process
causing various diseases[8, 9]. The human population shares about 99.5 percent of DNA codes,
and the remaining 0.5 percent makes it unique among the organisms. So, the study of SNPs to
reveal the molecular mechanism associated with human disease is essential. SNPs are of two
types, synonymous and non-synonymous. Synonymous mutations do not change the amino acid
(AA) sequence of the protein. Missense and nonsense mutations are two types of nonsynonymous mutations. Missense mutations change AA in the protein, and nonsense creates a
stop codon and results in premature truncation [10]. This dissertation will discuss the effects
caused by different missense mutations that are associated with various diseases.
Disease-causing mutations affect the function of the corresponding proteins. They can affect
proteins stability and their binding. They can also alter the conformation dynamics, hydrogen
bonding, salt bridges, electrostatic interactions, and the pH dependence of the proteins[4, 5, 1114]. There is a relation between the properties mentioned above and the propensity given
mutation to be pathogenic [15-19]. Therefore, the ability to correctly predict the change of wild-
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type properties of the corresponding macromolecules due to mutations is critical for disease
diagnostics.

1.3 Protein-Protein Interactions

Protein-protein interactions (PPIs) are abundant in the cell, it is estimated that each
protein on average interacts with four partners. It results in homodimers, heterodimers, enzyme
inhibitors, and antibody-protein complexes[2, 20-22]. They are involved in various biological
processes, so it is essential to understand the binding mechanism and predict the binding mode
of the biomolecules. The deviation of the wild-type patterns and related physical properties are
related to different diseases. PPIs alter the kinetic properties of the protein, and they are also the
standard mechanism to allow for substrate channeling, formation of binding sites, and drug
discovery[2, 22-24].
Modeling PPIs is a two-fold problem: predicting the binding pose and revealing the
binding trajectory. There are two major approaches for predicting binding pose as homology
modeling and docking, while much less attention has been paid to predicting the binding
pathway. This is very important for cases that require significant conformational changes
affecting backbone motion and opening of the binding pocket[25-28]. This dissertation discusses
the molecular dynamics (MD) simulation technique taking the electrostatic interactions into
account and addresses PPIs' binding trajectory and pose.

3

1.4 pH dependence of Protein Stability

The pH of a solution is an essential characteristic of many biological processes. pH
controls the macromolecular activities, and for every macromolecule, there is a particular pH at
which the macromolecule is the most stable and its activity is maximum. Macromolecular
interactions are also pH dependents, and there is typically a pH optimum at which the binding
affinity is maximum [14, 29, 30]. Subcellular compartments within a cell have different pHs,
reflecting their function, from low pH in lysosomes to high pH in peroxisomes. Increasing the
scale of this idea, pH plays a crucial role in body organ function and varies from very acidic in
the stomach to neutral in the blood. All the above examples indicate that the regulation and
maintenance of pH are essential for many biological phenomena. The pKa values of titratable
groups in macromolecules determine the pH dependence of their stability, interactions, and
enzymatic activity. Any changes in the pKa's may affect the wild-type properties of the
corresponding macromolecule[30-32]. This dissertation explains the pH dependence on the
stability of the melanosome proteins for the melanin formation and functions.
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CHAPTER TWO
MODELING ELECTROSTATICS IN MOLECULAR BIOLOGY

This chapter discusses popular software DelPhi and its associated resources to model
biomolecules' electrostatic potentials and energies. It explains some features, examples with
tutorials, and benchmarking results against analytical solutions.

2.1 DelPhi

As discussed in the previous chapter, electrostatics is an essential component in various
biological processes. The modeling of electrostatics is complex process in molecular biology
which is complicated due to the presence of water phase, mobile ions, and irregularly shaped
inhomogeneous biological macromolecules. To overcome these difficulties, the PoissonBoltzmann method is developed, which is a particular approach to calculating electrostatics
potential by using the Poisson-Boltzmann equation (PBE)[33, 34]. DelPhi is the popular
package that solves PBE using a finite difference method and delivers the electrostatics potential
throughout the modeling box[35-37]. The new Delhi C++ is an object-oriented PBE package
supporting various multiprocessing and memory distribution levels. The multiprocessing results
in a significant improvement in computational time. The memory distribution approach reduces
RAM requirement for large macromolecular assemblages and permits large-scale modeling in
Linux clusters with moderate architecture. The traditional implementation of PBE in molecular
biology considers that the biological macromolecules are low dielectric cavities immersed in the
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water phase, described as a continuum medium with a large dielectric constant. In this protocol,
ions are point charges that obey the Boltzmann distribution and can be present outside the socalled Stern layer. This implementation of PBE is two-dielectric PBE. In contrast, the Gaussianbased smooth dielectric function treats the solute and solvent on the same footage, and the
continuous dielectric function describes the entire computational space. This models the
macromolecules as inhomogeneous objects, and there is no sharp boundary between solutesolvent. Ions in such a scenario are point charges obeying Boltzmann distribution. Still, the
argument of the Boltzmann function has a desolvation penalty which does not allow ions to
propagate into the macromolecular interior unless there is a cavity. This approach is Gaussian
PBE[37-39]. Both techniques are used in various computational investigations and show that
they can be used for computing biologically measurable quantities.
DelPhi is available to all users worldwide. It is available in a standalone version
(http://compbio.clemson.edu/lab/delphisw/) and also can be used as the webserver
(http://compbio.clemson.edu/sapp/delphi_webserver/).

DelPhi's

other

resources

include

downloadable packages and webservers[40]. DelPhiPka [41]uses DelPhi to calculate the
protonation states of polar residues of protein and DNA/RNA at a given pH. DelPhiForce[42,
43] uses DelPhi to calculate electrostatics forces between protein-ligand, protein-protein, and
protein-DNA/RNA. There are packages available within the DelPhi to study the effect of
missense mutations on the folding free energy of Protein (SAAFEC)[44] and the binding affinity
of the protein-protein complexes (SAAMBE)[45] and protein-DNA complexes[46] (SAMPDI).
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2.2 Benchmarking Against Analytical Solutions

This section shows the benchmarking results of DelPhi delivered electrostatic energies
and their comparison with analytical solutions. This benchmarking is an ultimate test of the
accuracy of the DelPhi protocol and computer code. Several cases for which analytic solutions
can be delivered are shown in Figure 1-Figure 3. These include the electrostatic component of
solvation energy of a sphere immersed in solvent (Figure 1), the total electrostatic energy of two
charged sphere in a dielectric cavity (Figure 2), electrostatic energy of a spherical charge moving
across semi-infinite dielectric solvent (Figure 3: A and B) and the same for a spherical charge
approaching a cylinder (Figure 3: C and D). The semi-infinite dielectric solvent is modeled as a
box with dimensions 25x25x25A, and thus represents an approximation. The result clearly
indicates that DelPhi C++ delivered energies are matching analytical solutions.
It should be, clarified that in case of Figure 1, electrostatic solvation energy of a sphere,
the datapoint at scale=0.5 [grid/A] in case of sphere radius equal to 1A is not provided in the
graph. The reason is that finite-difference algorithm requires the size of the object larger than the
grid resolution (scale = 0.5 [grid/A] corresponds to grid resolution of 2A).
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Figure 1. (A) Schematic illustration of example 1: A charged sphere with low dielectric constant
is inside a Media with a high dielectric constant. (B) Electrostatic component of solvation
energies calculated by Delphi against the analytical solution

Figure 2. (A) Schematic illustration of example 2: a cavity with low dielectric constant is inside
a media with high dielectric constant. Two charged atoms are located inside the cavity. (B)
Electrostatic component of solvation energy obtained from Delphi compared with analytical
solution.
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Figure 3. (A) Schematic illustration of example3: A sphere in semi-infinite dielectric plane
(Box). A sphere with low dielectric constant ε1 is initially positioned in region with high
dielectric constant ε2 and moves into the region with low dielectric constant ε1 inside the box.(B)
Electrostatic component of solvation energy derived from Delphi compared with analytical
solution.(C) Schematic illustration of cylinder in two dielectric medium: A charged sphere with
low dielectric constant ε1 initially positioned with high dielectric constant ε2 and moves into
region of low dielectric constant ε1 inside the cylinder.(D) Electrostatic component of solvation
energy obtained from Delphi compared with analytical solution.

2.3 Tutorial Examples of DelPhi

DelPhi reads parameters, instructions, and other necessary details from a parameter file. The
parameter file contains names of files providing coordinates of biomolecules and if necessary,
the files with atomic charges and radii. Details instructions of parameter file and other details of
the

syntax

and

methods

are
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provided

in

online

tutorial

(https://github.com/delphi001/delphi_tutorial_livecoms/tree/master/LiveCoMS_Examples).
Here I describe two sets of examples showing how to set up parameter and other files to compute
various electrostatic quantities.
2.3.1 Computing solvation energy
In this section, I describe how to calculate electrostatic component of solvation energy, i.e,
∆𝐺𝑝 for a single atom and a real protein, as shown in Figure 4.
The case of single atom (a charged sphere) is considered because there is an analytical solution
via Born formula of charged ion, and the numerical solution provided by DelPhi can be compared
with the analytical. This also provide example of computing electrostatic solvation energy using
traditional two-dielectric model as well as the Gaussian smooth dielectric function PBE. The
corresponding files can be found in directory Example_3.1.1. and sub directories there in.
I will begin with the simplest case of charged sphere (see Example-3.1.1/EX1) using
traditional two-dielectric model. Consider a charged sphere of radius 3A carrying a charge +1
e.u. (electron units). Let’s consider that internal and external dielectric constants are 1 and 80,
respectively. Thus, the analytical solution is -92.33 kT. DelPhi can be executed using the files
provide in the above-mentioned directories as:

$DELPHI_EXE_param_charged_sphere.prm\ >Charged_sphere.log
After the run is completed, the user can find the corrected reaction field energy from the
output information in the log file, which is:
Energy > Corrected reaction field energy: -92.50 kT
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Thus, the numerical solution delivered DelPhi matches the analytical solution. Users can
check the sensitivity of results by changing their scale parameter.
Applying Gaussian-based smooth dielectric function approach on the same problem, the
charged sphere, results in different polar solvation energy. First, there is no analytical solution
since there is no longer hard sphere, but rather a spherical object with smooth dielectric function
having minimum value at the center of the sphere and smoothly reaching 80 in bulk solvent.
DelPhi can be executed with this example as:
$DELPHI_EXE_param_charged_sphere_gauss.prm\ > charged_sphere_gauss.log
The calculated polar solvation energy is in the log file:
Energy > Corrected reaction field energy: -211.20 kT
The other example of how to calculate polar solvation energy of a protein, all the related
files are kept in the directory Example_3.1.1/Ex2/. The DelPhi run for computing it via
traditional two-dielectric approach can be initiated using command below:
$DELPHI_EXE param_protein.prm > protein.log
After the run, the user can find the output information in the log file:
Energy > Corrected reaction field energy: -1005.07 kT
Similarly, modeling the same protein with Gaussian-based smooth dielectric function can be
done by invoking DelPhi and appropriate parameter file as:
$DELPHI_EXE param_protein_gauss.prm \ > protein_gauss.log
After the run is completed, one finds the output information in the log file:

Energy > Corrected reaction field energy: -3583.05 kT
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The slight difference in “corrected field energy” values for traditional two-dielectric and
Gaussian-based methods is because traditional two-dielectric approach is intending to deliver
solvation energy of a rigid molecule, while Gaussian-based methods intends to mimic the effect
of conformational changes. Use of traditional two-dielectric model with higher than 1.0 dielectric
constant represents a case of treating conformational changes uniformly, i.e, uniform flexibility.
However, macromolecules are not homogeneous objects. Instead, Gaussian-based model assigns
local dielectric values depending on atomic packing and thus reflects inhomogeneous nature of
proteins.
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Figure 4.The schematic representation of computation of solvation for (a) a charged sphere and
(b) a protein. The solvation of a molecular system consists of two components, non-polar
component ∆𝑮𝒏𝒑 and polar component ∆𝑮𝒑 . The non-polar components account for the energy
required to create a cavity to accommodate the molecular system (solute) in the solution or
moving solute from gas phase into solvent keeping solute atoms partial charges turned off, and
polar component accounts energy required to turn on the partial charges of solute atoms in the
solvent.

2.3.2 Computing electrostatic potential, energy of interaction and forces between two sets
of atoms
In this section, I will describe how to calculate the electrostatic potential, energy of
interaction and force between two sets of atoms using ‘frc’ option. Scheme is shown in Figure
5.
In the parameter file we need to add command “site (argument)”, specially in this case site
(a,p, f). This makes Delphi to report the potentials and electrostatic field component at the
positions of the subsets of atoms in the frc file. This calculation requires two types of pdb files,
one is “atoms.pdb” which contains co-ordinates of all atoms which contribute to the electrostatic
potential, and another is “atom-1.pdb” which contains a dummy atom to specify the coordinate
at which electrostatic potential and electric fields are required to be computed. The charge and
size information for all atoms present in atoms.pdb have to be provided in charge and size files
atoms.crg and atoms.siz respectively. In present case we attempt to calculate electrostatic
potential and electrostatic field at the origin due to a system of two atoms A1 and A2 whose
charges are q1 = 10 ec and q2 = 20ec respectively, the size of both atoms is 1.0𝐴̇, and coordinates
of A1 and A2 are (5.0, 5.0,0.0) and (5.0,0.0,0.0) respectively. Here charges are in unit of charge
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of proton i.e., ec and distance and coordinates are in 𝐴̇. A schematic representation of the system
is shown in Figure 5.
The analytical expression for such system is known and shown in equation 1. Therefore, we can
benchmark DelPhi results against analytical value. Since DelPhi unit of energy is
convert the analytical energy also in

𝐾𝐵𝑇
𝑒

𝐾𝐵𝑇
𝑒

, we shall

for comparison. Using Boltzmann constant 𝐾𝐵 =

1.38 × 10−23 𝐽𝐾 −1 , absolute temperature T = 297.33K (default temperature in DelPhi),
elementary charge 𝑒𝑐 = 1.6 × 10−19 𝐶, and external dielectric constant 𝜖𝑒𝑥𝑡 = 80, the potential
computed from equation 1 comes to be 38.035
38.1317

𝐾𝐵𝑇
𝑒

𝐾𝐵𝑇
𝑒

, while potential computed from DelPhi is

, which shows a relative error ~10−3 showing an excellent agreement to analytical

value.

∅=

1
𝑞1 𝑞2
( + )
4𝜋𝜀0 𝜀𝑒𝑥𝑡 𝑑1 𝑑2

(1)

Similarly, analytical values of X- and Y- components of electric field Ex and Ey at
position of A3 due to systems of charges A1 and A2 are -6.613
calculated from DelPhi are -6.7208

𝐾𝐵 𝑇
𝑒𝑐 𝐴̇

and -1.0031

𝐾𝐵 𝑇
𝑒𝑐 𝐴̇

𝐾𝐵 𝑇
𝑒𝑐 𝐴̇

and -0.993

𝐾𝐵 𝑇
,
𝑒𝑐 𝐴̇

while value

respectively, which are also in good

agreement to analytical values. All the required fields are provided in the directory
Example_3.1.4/.
Users can run DelPhi for this example using following command:
$DELPHI_EXE param_frc.prm > delphi_frc.log
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The output file i.e., atoms.frc contains necessary lines with all information regarding
potential and components of electric field. They can be further used to calculate energy of
interaction and force between two atoms. We can change the grid size and scale according to the
need.

Figure 5.The schematic representation of setup of example system for electrostatic potential,
energy of interaction and force between two sets of atoms (A3 due to A1 and A2).
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CHAPTER THREE

STUDY OF PROTEIN-PROTEIN INTERACTIONS

Ab-initio binding of barnase–barstar with DelPhiForce steered Molecular Dynamics
(DFMD) approach
3.1 Introduction

Protein-protein interactions (PPIs) are essential for numerous biological processes such
as cell to cell interactions, metabolic control and development [47]. This importance is
demonstrated by the fact that deviations of the wild-type patterns of PPIs and the corresponding
biophysical characteristics of protein complexes were shown to be associated with diseases [23,
48-54]. Upon the binding a protein-protein complex is formed and depending on the participating
monomers the complexes are classified as homo-dimers , hetero-dimers, enzyme-inhibitor and
antibody-protein complexes [55], just to mention some. Furthermore, these complexes are
characterized according to shape and size [56], complementarity between interfaces [57, 58],
residue interface propensities [59, 60] including hydrogen bonding [61] and secondary structure
[62]. Among the driving forces causing complex formation, the electrostatic interactions are the
only long-range interactions and thus play primary role in guiding the monomers toward the
binding. The electrostatics energies and forces were shown to play major role in different
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molecular phenomena such as PPIs, ion binding [53, 63-65], protein folding and stability [66,
67], protein -DNA/RNA interactions [68-70], and protein-microtubule binding [48, 71-73].

Modeling PPIs is a two-fold problem: predicting the binding pose and revealing the
binding trajectory. There are many approaches for predicting binding pose, including homology
modeling [25] and docking [26], while much less attention has been paid to predicting the
binding pathway. The last is very important for cases involving binding that requires large
conformational changes involving backbone motion [27] and opening of the binding pocket
[28].

The technique capable in principle of addressing both, the binding trajectory and the
binding pose, is molecular dynamics (MD) simulations of PPIs [74]. Essential component in
these MD simulations is the treatment of water phase: either with explicit solvent waters [75] or
Generalized Born (GB) implicit model [76, 77]. Explicit solvent model is computationally too
expensive when large complexes are involved, and monomers are separated at large distances.
Alternative is the GB model, which is much less computationally demanding. However, the
default setup of GB model involves cut-offs for both of Born radii and pair-wise energies
calculations. So, if the distance between receptor and ligand is large than the cut-off distance,
the default setup of GB model will result in omitting contributions of distant atoms and thus
affecting the modeling [78]. Increasing the cut-offs in MD setup presumably should solve this
issue, however it results in dramatical slowdown of the calculations and in addition, still does
not model electrostatic interactions correctly, as demonstrated in ref. [78].
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To address such a deficiency, in our previous work, we introduced a hybrid method, the
DelPhiForce steered MD (DFMD), that takes advantage of the accurate calculations of
electrostatic forces at each atom of the ligand and ports these forces into steered MD [78]. It was
demonstrated that DFMD correctly predicts the binding trajectory (the entrance of the binding
pocket) and binding pose of a small ligand (spermidine) bound to a receptor (spermine synthase)
[78]. However, DFMD has never been tested on PPIs. Here we extend the applicability of DFMD
by applying it to model binding of barstar to barnase. We show that DFMD is capable of guiding
barstar-barnase complex formation irrelevant of the starting positions and orientations of
separated monomers.

3.2 Materials and Methods

3.2.1 Delphi
Delphi is a popular software that solves the Poisson-Boltzmann equation (PBE), which uses
finite difference method to compute electrostatic potential distribution throughout the modeling
box [36, 79, 80].
3.2.2 DelPhiForce
DelPhiForce (http://compbio.clemson.edu/delphi-force) is available within Delphi package
to calculate the electric field, forces, and energy of a two-molecular system. In our study it is
used to compute the electric force between receptor and ligand. The receptor’s atoms are charged
using amber force field [81] and ligand’s atoms are kept neutral. Then Delphi uses finite
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difference approach to solve the PBE and computes the electrostatic potential at each atom of
ligands due to charge in the receptor atoms, and from there to deliver the atomic electrostatic
forces [42, 43].

3.2.3 DelPhiForce steered Molecular Dynamics (DFMD) simulations
We used DFMD [78] method to study the binding of ligand to receptor, the barstar binding
to the barnase. The DFMD method uses an approach that combines long range electrostatic force
via DelPhiForce and NAMD MD simulation package [82]. The ligand (barstar) was offset 30
Angstroms away from of its bound position to assure that the only none zero force is the longrange electrostatic force. Then the electrostatic force on each atom of barstar was calculated with
DelPhiForce [42, 43]. The forces are then given to steered MD module of NAMD [82].
Simulations were done with Generalized Born implicit solvent model (GBIS) [83]. The ion
concentration was 0.15M, solvent dielectric was 80 and temperature was maintained at 300 K
using a Langevin thermostat. In addition, cut off was taken at 18 Å and periodic boundary
conditions were applied with a cubical box of 150 Å. Constant pulling forces were applied in
the simulations where the direction and magnitude of the steered forces were calculated by
DelPhiForce [42, 43, 83]. The steered force was recalculated and updated every 500 steps of the
simulations. The simulations were done using default value of steered electrostatic force range:
low limit 0.2 kcal mol-1Å-1 and upper limit 1.18 kcal mol-1Å-1.
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3.2.4 Selection and preparation of barnase and barstar monomers
The barnase-barstar complex structure was taken from Protein Data Bank (PDB ID:
1BRS)[84] and we selected chain ‘C’ as barnase and chain ‘F’ as barstar. The PDB file had two
mutations, C80A and C82A with respect to wild-type and these mutations has been mutated back
to wild-type residues. The reverse mutations were performed using UCSF Chimera [85] where
rotameric state with highest occupancy in Dunbrach library of rotamers is utilized.
The distance between the center of mass (CoM) of barnase and barstar complex is calculated
as 23.39 Angstrom using VMD [86]. The CoM of barnase is positioned at the origin of the
reference frame and barstar is rotated around the axes passing through the CoM of barnase so
that CoM of barstar resides on X- axis (Figure 6). The starting positions for each simulation are
obtained by offsetting barstar 30 Å away from its bound position (DD = 30 Å) along X-axis. To
generate alternative unbound orientations for barnase and barstar, 64 initial structures with
different relative orientations of barstar and barnase were created. The first set was generated
keeping barnase orientation fixed, while barstar was rotated around X- and Z- axes passing
through its CoM in increments of 90 degrees. Then the same procedure is repeated for 4
orientations of barnase rotating it around Y-axis passing through its CoM (Figure 6a-d).
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Figure 6. Selection and manipulations of barnase and barstar monomers: (a) experimental
structure of barnase-barstar complex with center of mass (CoM) distance denoted by D (left
barnase and right barstar); (b) barnase-barstar complex separated by DD=30 Å between centers
of mass; (c) different initial orientations of barnase created by rotating barnase about Y axis
through its center of mass with increments of 90 degrees steps; (d) different initial orientations
of barstar created by rotating barstar about X- and Z- axes though its center of mass with
increments of 90 degrees steps.
3.2.5 Ligand RMSD and interface RMSD
Ligand RMSD (L-RMSD) is the RMSD of ligand obtained through the superimposition of
the receptor docking model to its crystallographic structure and then computing the RMSD of
the ligand [87]. The interface RMSD (I-RMSD) is the backbone RMSD of interface residues of
the ligand [88].
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3.3 Results

Sixty-four independent DFMD simulations were carried out staring from different positions
and orientations of both barnase and barstar. The success of the modeling was monitored via
several quantities, mentioned in Methods section: L-RMSD, I-RMSD and the offset from
crystallographic bound position (D). Here we provide the results of the simulations by showing
several showcase examples and then statistics of the entire set of simulations.
3.3.1 Showcase examples
It is not anticipated that each simulation will result in successful binding, because the
simulation time is relatively short (5ns) and the binding process may involve transient binding
at wrong places before the correct binding mode is found. Therefore, here we present two
successful cases (Figure 7), simply to illustrate that DFMD can bind correctly relatively large
proteins even the initial positions and orientations are completely away from the crystallographic
ones (the same simulation without DelPhiForce assistance resulted in no binding). The first case
is DFMD simulation with initial positions and orientations of monomers as: barnase fixed in its
crystallographic position while barstar is moved away by D = 30 Å along X-axis and rotated
90 degree around X-axis and 270 degree around Z- axis (see Figure 6 for more detail). In the
second case the initial positions and orientations of monomers are: barnase rotated 90 degrees
along Y-axis and barstar moved away along X-axis by D = 30 A and rotated 270 degree along
Z- axis. Both cases clearly represent difficult binding initial conditions, especially the second
case where both binding interfaces are in completely wrong orientations. Nevertheless, 5ns
DFMD simulations are quite successful as shown in Figure 7
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The results show the L-RMSD approaches 10 Å limit, which is the cutoff used in Critical
Assessment of Predicted Interactions (CAPRI) to indicate acceptable predictions [87]. It is
important to observe that once the near-binding-mode is achieved, the L-RMSD does not change
much and the system is quite stable (Figure 7a, b). The assessment of the success of simulation
is also done via monitoring D. Indeed, one sees that D goes quickly to near zero, indicating
the binding partners are situated at almost the same distance as seen in crystallographic structure
(Figure 7 a,b). Furthermore, we monitored I-RMSD for both cases (Figure 7a, b). Similar
observations as above can be made – the system quickly reaches a binding pose that is very
similar to the crystallographic one and stays stable during the rest of simulations. The reason
why the system does not exactly reach the crystallographic conformation is the internal
flexibility of both the receptor and the ligand. They sample conformations that are several Å
RMSD away from their crystallographic structures, an observation that have been reported by
other researchers as well [89]. The final positions of barnase-barstar at the end of simulation
compared to their native structures are also shown for guidance of the eye (Figure 7c-d).
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Figure 7. L-RMSD, D and I-RMSD as a function of simulation time (a) L-RMSD , I-RMSD &
D of barnase-barstar at different time steps during the simulation with barnase fixed and barstar
rotated 90 degree around X-axis and 270 degree around Z- axis passing through CoM; (b) LRMSD, I-RMSD and D at different time step during the simulation with barnase rotated 90
degree around Y-axis and barstar rotated 270 degree around Z- axis passing through CoM; (c,d):
final position of barnase -barstar at the last step of simulation compared to experimental structure
when the simulation is performed with initial orientations explained for (a) and (b) respectively:
barnase colored green and barstar colored purple, while experimental structures are colored red
(barnase) and yellow (barstar).

3.3.2 Statistical analysis
Statistical analysis shows that most of the simulations are successful despite of the short
simulation time. To illustrate the time evolution of the quantities (D, L-RMSD and I-RMSD)
that are used in this work to access the success of simulations, we select several time-windows
from the DFMD simulations (time-windows 2-3, 3-4, and 4-5ns). Each time window consists of
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4000 frames. One anticipates that longer simulations will bring the ligand closer to the
crystallographic binding position. Results are shown in Figure 8. Analyzing the offset distance,
the D (Figure 8a), one sees that the number of cases with very small D is greater for the timewindows 3-4ns and 4-5ns compared with the time-window 2-3ns. This indicates that indeed as
the time of simulations progresses the DFMD brings the partners together close to the
experimental positions. Furthermore, Figure 8b shows the time evolution of L-RMSD in these
three time-windows separately. Here the trend is not as clear as it is for D. Practically there is
no difference of the number of cases with low L-RMSD between the three time-windows.
However, there is a tendency in the range of L-RMSD 60-90 Å, that longer simulations provide
better outcome, i.e., less cases being with such large L-RMSD. It should be made clear that LRMSD has three components: L-RMSD due to (1) offset distance, (2) wrong orientation of the
ligand and (3) conformational changes of the ligand. In addition, due to the fact that the receptor
also undergoes conformational changes during the simulations, the structural superimposition of
crystallographic 3D structure of the receptor and the corresponding snapshot is contributing to
L-RMSD as well. Finally, the results about I-RMSD are shown in Figure 8c. Here we see both
effects mentioned above: an enrichment of case with low I-RMSD for time-windows 3-4ns and
4-5ns compared with case in the time window 2-3ns, and at the same time fewer cases in the
regions 60-90 Å. The arguments about the factors contributing to I-RMSD are the same as
outlined for L-RMSD.

Overall,

the statistical analysis indicates that DFMD facilitates the binding and attempts to

bring the apartments to their crystallographic positions in the complex. However, none of 64
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simulations resulted in perfect match of the binding mode of barnase-barstar complex as seen in
the crystallographic structure, i.e. D = 0 Å, L-RMSD = 0 Å and L=RMSD = 0 Å. One plausible
reason for that is in our protocol the structures are not rigid and they sample various
conformations (away from crystallographic 3D structures) and thus even they are sampling the
crystallographic binding mode, still the corresponding D, L-RMSD and I-RMSD will be
different from zero.

Figure 8. Statistical analysis of the results based on ∆D, L-RMSD and I-RMSD during different
time- windows of the simulations (a) analysis of ∆D; (b) analysis of L-RMSD; (c) analysis of IRMSD

3.3.3 Role of electrostatics
The work was done on diverse set of initial orientations and positions of both barnase
and its ligand barstar. We did not observe preference of successful binding with respect to the
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corresponding initial conditions. In some cases, as case 2 in the showcase section, the partners
were positioned and oriented in completely wrong way (by wrong we mean positions and
orientations completely different from crystallographic ones), and still DFMD was able to
correctly bring them together very close to the crystallographic binding mode. What is the reason
for that? Error! Reference source not found. illustrates two cases of initial conditions, an easy
case where the barstar is simply moved away from its crystallographic position (Error!
Reference source not found.a) and a difficult case, where barstar is moved away and rotated as
well (Error! Reference source not found.b). In the first case (a) the binding interfaces are still
facing each other and presumably the recognition should be easier. Indeed, as it can be seen in
Error! Reference source not found.a, the resulting electrostatic force coming from barnase and
acting on barsar is pointing toward the receptor, thus contributing to the association process. In
the second case (Error! Reference source not found.b), the interfaces are not facing each other
and if the barsar is simply pulled toward the barnase, the binding will be totally wrong. However,
Error! Reference source not found.b indicates that the electrostatic play crucial role by
providing a torque that makes barstar to rotate and thus to adopt correct orientation of the binding
interface. Such an electrostatic torque effect was shown to be common for various binding
partners [42].
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Figure 9. Electrostatic forces generated by barnase (cartoon representation) to barstar placed 30
Å away from its bound position. Orange arrows represent forces acting on each residue, while
the green arrow is the total resultant force. The length of the arrow reflects calculated magnitude
of the force. The side chain of residues of barstar are represented as line, of which blue and red
positively charged residue and negatively charged residue respectively: (a) initial
crystallographic structure of barnase-barstar separated by 30 Å from its bound position; (b)
electrostatic torque formed when keeping barnase fixed, barstar is rotated around X-axis by 90
degree and around Z-axis by 270 degree and separated by 30 Å to its bound position.

3.3.4 Role of conformational flexibility and longer simulation time
It was mentioned above that none of the simulations resulted in a perfect binding mode. The
corresponding quantities, D, L-RMSD and I-RMSD were found to be different from zero in all
64 runs. To probe what is the plausible reason for that, we carried out traditional MD simulations
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(without DelPhiForce) staring from the crystallographic structure of barnase-barstar complex.
The results of 5ns simulations are shown in Figure 10a. It can be seen that D, L-RMSD and IRMSD are different from zero, confirming our initial thought that conformational dynamics
associated with MD results in deviation from crystallographic structure and thus one cannot
expect that DFMD modeling will reproduce the binding mode seen in X-ray experiment.
Furthermore, we tested if the DelPhiForce could be causing problems when monomers are
in bound state. For this purpose, we carried out DFMD simulations starting from the X-ray
structure of the complex (Figure 10b). One can compare Figure 10a and Figure 10b to observe
that there is not significant difference. This indicates that DFMD in bound state delivers results
similar to traditional MD and does not cause artifacts.
Finally, one may expect that longer simulations will provide better results. To quickly probe
this, we took a particular case of binding mode resulting in small ∆D, L-RMSD and I-RMSD
(taken from the last frame of the simulations shown in Figure 10b) and subjected it to additional
5ns NAMD. Results are shown in Figure 10c. Unfortunately, no improvement was observed.
This suggests that DFMD should not be targeted to deliver the “perfect” binding mode, but rather
to position the binding partners in a near-binding mode.
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Figure 10. L-RMSD, I-RMSD and ∆D as a function of simulation time: (a) NAMD simulation
of bound crystal structure; (b) DFMD simulation of bound crystal structure; (c) NAMD
simulation of last frame of the successful DFMD simulation.

3.4 Conclusions

This work showed that DFMD is capable of assisting modeling of protein-protein binding
and produces trajectories that describe various scenarios, including case at which the starting
positions and orientations are completely different from the binding ones. At the same time, the
approach is fast and computationally less expensive than traditional MD-based approaches.
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CHAPTER FOUR
EFFECT OF DISEASE-CAUSING DNA VARIANTS IN PROTEIN STABILITY,
DYNAMICS, AND INTERACTION
In-silico analysis to identify the role of MEN1 missense mutations in breast cancer
4.1 Introduction

Variants in MEN1 gene has been found to have a strong association with multiple
endocrine neoplasia type 1 that follows an autosomal dominant (AD) inheritance pattern in
various tumor syndromes[90]. MEN1 triggered neoplasia type1 is involved in the development
of various tumors such as parathyroid adenomas, duodenopancreatic neuroendocrine tumors, and
pituitary (anterior) adenomas with a 94% penetrance by the age of 40[91]. MEN1 encodes for
menin, a 610 amino acid oncosuppressor protein, found in the nucleus. Menin protein interacts
with other proteins such as JunD/AP1, Smad3, NFκB, estrogen receptor (ER) and others to
participate in various transcription and cell signaling processes[92].
The inheritance of germline MEN1 mutation such as a point mutation or deletion (leading
to loss of heterozygosity (LOH)), disrupts the signaling pathway of menin protein, and thus
predisposes an individual to develop tumor. The germline mutations occurring in MEN1 that
truncate the menin protein result in dysfunctional product and thus affecting its role in tumor
suppressor activity[92]. Studies based on mutagenesis performed previously indicate that the
LOH of menin protein disrupts its interaction with histone methyltransferase (HMT) mixed
lineage leukemia protein (MLL). This mechanism in turn impacts histone associated
trimethylation (H3K4me3) transcription activation process thus fails to suppress the
development of endocrine tumors[93].
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The oncosuppressor menin protein plays a vital role in suppression of ER-positive breast
cancer as well[94]. Previous studies outline that the upregulation of menin protein which binds
to the ER and thus enhances the ER activity which implicates that it acts as a growth stimulator
in ER-positive breast cancer[95]. Menin also regulates ERα-mediated transcription by enhancing
H3K4 (histone 3 lysine 4) methylation process leading to breast carcinogenesis and various other
tumor progression mechanisms[96]..Loss of heterozygosity (LOH) and disruption in menin
protein expression in a Dutch cohort strongly shows involvement of MEN1 in breast cancer
carcinogenesis[97].
The goal of this study is to classify missense MEN1 variants reported to be identified in
breast cancer tissues from COSMIC (Catalogue of Somatic Mutations in Cancer) database[98]
with unknown pathogenicity. This is done by applying our combinatory in-silico predictor[99]
approach to annotate the pathogenicity of these variants. We also analyzed the impact of these
variants on biochemical and biophysical properties of the menin protein along with the in-house
built menin-ER and menin-MLL complexes. In parallel the same is done for curated pathogenic
variants causing neoplasia. Comparing the observations made for mutations associated with
neoplasia and variants in COSMIC database along with predictions made by our in-silico
predictor, we provide classification of pathogenic menin mutations associated with breast
tumorigenesis.
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4.2 Materials & Methods

4.2.1 Selection of the MEN1 variants
We collected 19 unique missense variants in MEN1 gene (GRch37 version) from COSMIC
database that are reported to be identified in breast cancer samples. Among these 19 variants,
only 2 are listed in ClinVar[100]and they are annotated as variants of unknown significance
(VUS).
In parallel, we obtained 8 MEN1 missense variants associated with multiple endocrine
neoplasia type1 from ClinVar database categorized as pathogenic. We will use these pathogenic
mutations to compare their effect on menin stability and interactions with the effect caused by
variants taken from COSMIC database and 5 benign variants from VariSNP database[101], since
there were no benign variants reported in ClinVar.

Table 1 summarizes the list of all variants used in this study.
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Table 1. List of all the variants used in our study. The MEN1 missense variants associated with
breast cancer are obtained from COSMIC database, whereas the MEN1 pathogenic missense
variants associated with Multiple Endocrine Neoplasia are obtained from ClinVar (that is used
as a benchmarking set)
Protein
Change

Clinical
Significance

S606C
S606Y
L605V
M563I
K562M
P534A
T530I
R490Q
Q398E
A289E
L272R
S258L
V220M
H204Y
E200K
C170Y
R108P
L89R
L36F

Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow
Unknow

W441R
A373D
E260K
V189E
A165P
R280K
D423N

Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic

H139D

Pathogenic

rs# (dbSNP)

Phenotype List

Breast Cancer Associated Variants (COSMIC)
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
rs750591216
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
rs386134259
Breast Cancer
rs794728621
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
.
Breast Cancer
Breast Cancer
Neoplasia Associated Variants (ClinVar)
rs104894259
Multiple endocrine neoplasia, type 1
rs1555164707
Multiple endocrine neoplasia, type 1
rs104894268
Multiple endocrine neoplasia, type 1
rs104894262
Multiple endocrine neoplasia, type 1
Multiple endocrine neoplasia, type 1
Multiple endocrine neoplasia, type 1
rs104894264
Hereditary cancer-predisposing syndrome;
Multiple endocrine neoplasia, type 1
rs104894263
Hereditary cancer-predisposing syndrome;
Multiple endocrine neoplasia, type 1
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Source

COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
COSMIC
ClinVar
ClinVar
ClinVar
ClinVar
ClinVar
ClinVar
ClinVar
ClinVar

P519S
V555L
I377T
E371D
G508D

Benign
Benign
Benign
Benign
Benign

MEN1 Benign Variants (VariSNP)
rs150202288
NA
rs562257963
NA
rs115859693
NA
rs149383809
NA
rs375804228
NA

VariSNP
VariSNP
VariSNP
VariSNP
VariSNP

4.2.2 In-house algorithm for pathogenicity prediction
Recently we reported a combinatory in-silico predictor of pathogenicity[99] which combines
the 8 best pathogenicity prediction algorithms such as Polyphen2 (Polymorphism Phenotyping
V-2)[102], LRT (Likelihood ratio test)[103], MetaSVM[104], VEST3[105], PROVEAN
(Protein Variation Effect Analyzer)[106], REVEL[107], Eigen[108], CADD (Combined
Annotation Dependent Depletion)[109]. We used this method to characterize the pathogenicity
of the missense variant.

4.2.3 Annotating MEN1 missense variants
We also annotated these variants with allele frequency information from 1000 genome[110]
and Genome Aggregation Database (gnomAD)[111] to see the distribution of these variants
among various population groups. We also annotated the variants with GERP++ scores [112] to
evaluate the evolutionary conservation on a functional sequence. We used this score along with
another biochemical feature, the folding energy change, to build an in-house classification
method (using KNN classification method) to characterize the pathogenicity of missense
variants.
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4.2.4 3D model of Menin protein and generation of Menin-ER and Menin-MLL complexes
The crystal structure of menin protein was obtained from Protein Data Bank (PDB)[113].
The PDB file (ID: 3U84) contains two chains, chain A and chain B, and has missing residues.
The structure was re-modeled using SWISS-model[25] resulting in a full-length protein. (Figure
11A). The structure of ER was modeled with SWISS-modeling using its amino acid sequence
taken from Uniprot (ID: Q99527)[114] and a template (PDB ID: 4ZNH) with high sequence
similarity (sequence similarity of 0.59) to build the model (Figure 11B). The structure of MLL
was taken from PDB file (ID:4GQ6). Then the structures of menin, ER and MLL were used to
model the complexes menin-ER and menin-MLL. For this purpose, we used the docking
methods ZDOCK[115] and HawkDock[116]. Among the different models given by both
methods, one best model is chosen from each method, each with similar position and near to the
binding site of the protein. The binding site is predicted using web server meta -PPISP[117]
which gives consensus results based on three individual web servers: cons-PPISP[118],
PINUP[119] and Promate[120] (Figure 12A-D).
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Figure 11. 3D Protein Structure(A) 3D structure of menin; (B) 3D structure of Estrogen Receptor
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Figure 12. 3D structure of menin –ER and menin –MLL complex (A) 3D structure of menin-ER
complex from ZDOCK (blue colored chain menin and purple colored chain ER; (B) 3D structure
of menin-ER complex from HawkDock (cyan colored chain menin and pink colored chain ER);
(C) 3D structure of menin-MLL complex from ZDOCK (orange colored chain menin and purple
colored chain ER); (D) 3D structure of menin-MLL complex from HawkDock (green colored
chain menin and blue colored chain ER).

4.2.5 Computing folding free energy change due to mutation
Folding free energy change due to mutation was computed via in-house tool, the
SAAFEC[44] algorithm, along with third party webservers as DUET[121], CUPSAT[122],
mCSM[123], SDM[124] and I-Mutant 2.0[125].

4.2.6 Computing binding free energy change due to mutation
The change of the binding free energy of menin-ER and menin-MLL complexes was
computed with in-house algorithm, the SAAMBE[45] method, along with third party tools as
BeAtMuSiC[126], mCSM-PPI2[127] and MutaBind[128].
4.2.7 K-Nearest Neighbors (KNN) classification
K-nearest neighbors algorithm was used to classify the missense mutations using
biochemical property along with rate of evolutionary conservation. The dataset includes total of
32 missense mutations. We split this dataset set into two subset (1) train dataset that comprises
of 13 (5 Benign and 8 pathogenic) mutations; (2) test dataset consists of all the 19 mutations
from COSMIC database (non-classified/unknown effect mutations). The KNN classification was
performed using R program and various numbers of K values were tested to obtain the best
performance on the training dataset.
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4.3 Results & Discussion

4.3.1 Predicting pathogenicity of MEN1 variants
To evaluate the pathogenicity of the 19 MEN1 missense variants taken from COSMIC
database we utilized the in-house combinatory approach described in method section[99]. Table
3 (Appendix B) summarizes the score and the assessment from the approach. According to this,
15 out of 19 variants are classified as “pathogenic” and 4 variants are categorized as “benign”.
In order to add more evidence to our categorization we mined Uniprot database to see if any of
15 predicted pathogenic variants has reported to have damaging effect on the menin protein,
including associations with other disorders. We noticed that some of the variants from COSMIC
database classified as pathogenic (by our in-house combinatory approach) such as V220M and
A289E are also listed in Uniprot database as causing damage to menin protein and resulting in
neoplasia. This provides additional confidence that our predictions are correct and indeed
V220M and A289E are pathogenic mutations.
We did not find any allele frequency information associated with 18 variants except for one
variant (T530I) categorized as “benign” that shows an allele frequency of <5% from both 1000
genome[110] and gnomAD[111] databases. The results from our conservation analysis from
GERP++[112] on our dataset, show that all the pathogenic variants have evolutionary
conservation rate of larger than 4, while the benign variants have evolutionary conservation rates
ranging between 2 and 4.6. Studies have shown that high rates of evolutionary conservation
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along with other factors such as biochemical changes could contribute to the disruption of protein
function[129].
4.3.2 Mapping the missense mutations onto the Menin-MLL & Menin-ER complex
All the 19 variants taken from the COSMIC database, out of which 15 were predicted to be
pathogenic and 4 to be benign, are mapped in the complex structures of menin-ER and meninMLL complex, along with neoplasia-causing mutations and 5 benign mutations from VariSNP
database[101] (Figure 13). It can be seen that all the variants are scattered within the structure
and no variants are found near the interface of the protein complexes, both menin-ER and meninMLL complexes. Neoplasia mutations are found in helixes, beta sheet and loops whereas,
COSMIC pathogenic mutations are found in helixes and loops and benign mutations are found
in loops except mutation L605Y which is found in helix.
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Figure 13. Mapping of pathogenic and benign mutations to menin-ER and menin- MLL
complexes (A) mapping of mutations to menin-ER complex from ZDOCK (red colored
pathogenic mutations from COSMIC , yellow colored pathogenic mutations associated with
Neoplasia from ClinVar, green colored benign mutations from COSMIC and VariSNP); (B)
mapping of mutations to menin-ER complex from HawkDock (red colored pathogenic mutations
from COSMIC , yellow colored pathogenic mutations associated with Neoplasia from ClinVar,
green colored benign mutations from COSMIC and VariSNP); (C) mapping of mutations to
menin-MLL complex from ZDOCK (blue colored pathogenic mutations from COSMIC, yellow
colored pathogenic mutations associated with Neoplasia from ClinVar , green benign mutations
from COSMIC and VariSNP), (D) mapping of mutations to menin-MLL complex from
HawkDock (red colored pathogenic mutations from COSMIC, yellow colored pathogenic
mutations associated with Neoplasia from ClinVar ,magenta colored benign mutations from
COSMIC and VariSNP).
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4.3.3 Effect of missense mutation on protein stability
We find that most of the mutations destabilize the menin protein Table 4 (Appendix B). The
changes in stability are greater for the pathogenic mutations compared with the benign mutations.
Out of fifteen pathogenic mutations, eight are predicted to cause folding free energy change
greater than or equal to 1.50 kcal/mol, four to result in folding free energy change less than 1.5
kcal/mol and three to less than 1 kcal/mol. Out of nine benign mutations, only one is predicted
to cause change in folding free energy greater than 1.5kcal/mol, six are predicted to cause change
in folding free energy less than 1 kcal/mol and two greater than 1kcal/mol and but less than 1.5
kcal/mol. The results indicate that pathogenic mutations tend to cause larger changes of folding
free energy compared with predicted for benign mutations. Some of the pathogenic mutations as
A289E, R108P and L36F are predicted by all predictors to result in similar change of stability
which provides confidence that they are correct. These results can be compared with the change
in folding free energy due to pathogenic mutations associated with neoplasia reported to ClinVar
(Table 5, Appendix B). It is shown out of eight mutations associated with neoplasia, six have
folding free energy change greater than 1.5 kcal/mol and two have less than 1.5 kcal/mol. This
shows that pathogenic mutations associated with neoplasia and mutations from COSMIC
database predicted to be pathogenic have similar effect on protein stability.

4.3.4 Effect of missense mutation on binding affinity
Table 6 and Table 7 (Appendix B) show the change in binding free energy due to mutations
in menin-ER and menin-MLL complexes, respectively. For both complexes, all the mutations
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destabilize the protein binding but the changes in binding energy are greater for pathogenic
mutation compared with benign mutations. Out of 15 pathogenic mutations, 9 from menin-ER
complex are predicted to cause binding free energy to change greater than 0.5 kcal/mol and 6 to
less than 0.5 kcal/mol. In menin-MLL complex, 11 mutations are predicted to cause change in
binding free energy greater than 0.5 kcal/mol and only four to less than 0.5kcal/mol. Mutations
as A289E, C170Y and L272R are predicted to have largest effect on binding free energy change
for all methods. Most of the benign mutations of both complexes are predicted to cause change
in binding energy less than 0.5kcal/mol which is lower in comparison to pathogenic mutations.
These can be compared with the change in binding free energy due to mutations associated with
neoplasia reported in ClinVar (Table 8 and Table 9, Appendix B). It is shown that out of eight
pathogenic mutations associated with neoplasia in menin_ER complex, four are predicted to
cause binding free energy to change greater than or equal to 1.0 kcal/mol, three to cause change
in binding free energy greater than 0.5 kcal/mol and less than 1.0 kcal/mol and one to less than
0.5kcal/mol. For menin-MLL complex, five are predicted to cause binding energy change to
greater than 1.0 kcal/mol, two to greater than 0.5 kcal mol and less than 1.0 kcal/mol and one to
less than 0.5kcal/mol. This shows the similar binding effects of pathogenic mutations associated
with neoplasia and mutations predicted to be pathogenic and associated with breast cancer from
COSMIC database.

4.3.5 Biophysical properties-based pathogenicity classification using KNN model
Here we use KNN method along with biophysical features such as folding free energy (ΔΔG)
and conservation score (GERP++) to characterize the 19 MEN1 missense variants from
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COSMIC database. The dataset has a total of 32 mutation that encompasses 23 pathogenic
mutations and 9 benign mutations. These 32 mutations were partitioned into 13 mutations
(composed from ClinVar and VariSNP data sources) and 19 mutations with unknow significance
(obtained from COSMIC database) and then subjected to the KNN classifications. The 13 well
curated mutations were randomly split into 80% as train dataset and 20% as test data and we
preformed 10-fold cross validation. At 100% accuracy we identified the best K value is 5. Using
the validated KNN classification model with a K = 5 we performed the categorization of the 19
mutations with unknown significance with both features (GERP++ and ΔΔG) and just folding
free energy (ΔΔG). Table 10 (Appendix B) summarizes the predictions results from our KNN
classification and compares with the results obtained from our combinatory approach. When we
use the both the GERP++ scores and ΔΔG as features, two mutations that were predicted benign,
Q398E and L605V, in our combinatory in-silico approach were predicted to be pathogenic. But
when only ΔΔG was used as a feature, three mutation, S606Y, H204Yand M563I that was
predicted as benign using KNN classification differs from the results our combinatory in-silico
method prediction. Previous studies on contribution of biophysical property such as folding free
energy change (ΔΔG) has been used characterization of the pathogenicity of the missense
variants in MEN1[130]. Our results from KNN classification shows that the biophysical property
such as folding free energy along with evolutionary conservation rates provide more evidence in
characterizing the mutation deleteriousness.
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4.4 Conclusions

The study investigated the effects of MEN1 missense mutations and their role in breast
cancer. Our utilization of combinatory in-silico predictor approach characterized the
pathogenicity of the 19 missense variants with unknown clinical significance taken from
COSMIC database. The results from the biophysical analysis using the menin protein along with
its complexes (menin-MLL and menin-ER) aided in providing more evidence to the pathogenic
impact caused by the variants in breast cancer tissues. The results from our in-house KNN
classification method show strong correlation with the results from our in-silico combinatory
approach. Furthermore, the benchmarking of the results using the neoplasia exclusive variants
indicates that mutations clearly alter the protein stability of menin, and the changes are
comparable with predicted pathogenic mutations taken from COSMIC database. Taken together,
we provide classification of variants found in breast cancer tissues as pathogenic and benign
based on several features.
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CHAPTER 5
pH DEPENDANCE OF STABILITY DUE TO MUTATIONS

Computational Investigation of the pH Dependence of Stability of Melanosome Proteins:
Implication for Melanosome formation and Disease
5.1 Introduction

The pH of a solution is an important characteristic for many biological processes. On a
molecular level, the pH controls macromolecular stability and at extreme pH (acidic or basic
extremes) macromolecules unfold. Typically, for every macromolecule, there is a particular pH
at which the macromolecule is the most stable and activity is maximum, termed the pHoptimum[68, 131]. Macromolecular interactions are also pH-dependent[31, 132, 133] and
typically there is a pH-optimum at which the binding affinity is maximum[134]. Within a cell,
subcellular compartments have different pHs, reflecting their function, from low pH in
lysosomes to high pH in peroxisomes. Thus, macromolecules tend to have a pH-optimum that is
ideal for the pH of the subcellular compartment where they reside[135]. Increasing the scale of
this idea, pH plays a crucial role for body organ function and varies form very acidic in the
stomach to neutral in the blood. All above examples indicate that the regulation and maintenance
of pH is essential for many biological phenomena.
pH is maintained in a given cellular compartment by channels and/or pumps either
directly trafficking H+ or indirectly providing environments that affect local H+ concentration.
These channels and/or pumps can be termed positive (increase pH) or negative (decrease pH)
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regulators[136, 137]. Reaching and maintaining the desired pH depends on the balance of H+
flux controlled by these regulators, including the passive transport across the membrane (Figure
14). One would expect that the positive regulators have activity at acidic pH and almost no
activity at basic pH since their role is to increase pH from low to high pH. The converse would
be expected for negative regulators; activity increases as the pH rises. At a particular pH, the
inward and outward flux of H+ induced by positive and negative regulators become equal and
the pH set-point is established (Figure 14).

Figure 14. Schematic representation of the induced H+ flux of positive (increase pH) and negative
(decrease pH) regulators. With vertical arrow we indicate the desired pH, at which the total
induced H+ flux is zero.

Melanocytes are a specialized cell type that resides in the skin, eyes, brain, ear, heart,
lung and adipose tissue[138]. One of the primary functions of melanocytes is the production of
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melanin, a polymer of tyrosine derivatives that has important chemical properties in a wide range
of tissues[139]. Melanin is synthesized in a specialized organelle called the melanosome. The
pH of this organelle varies during the development of the organelle (a multistage process called
maturation) and contributes to common pigmentation variation in human skin, hair, and eye
color. Biallelic rare variants in proteins critical for the production of melanin, hair, and eyes,
(TYR) or in pH regulation of the melanosome (OCA2 and SLC45A2) lead to a significant
reduction in melanin pigmentation in skin and give rise to Oculocutaneous albinism (OCA)
(OCA1, OCA2 and OCA4 respectively). Melanin synthesis is critical for the protection of the
skin and eyes from ultraviolet radiation and a reduction in melanin synthesis increases the risk
of cancer. Furthermore, a dramatic reduction of melanin production in the eye is also correlated
with foveal hypoplasia, reduced visual acuity, and photophobia among individuals with
OCA[140]. Taken together, the link between altered melanin pigment production and disease is
well documented, however it remains poorly understood how the pH set-point of this organelle
affects protein function which is critical for melanin synthesis or organelle pH maintenance
[141].
Melanosomes originate from the endosome (Figure 15); thus, early melanosomes have a
low pH (~ 3–4), whereas in the latter stages the pH reaches a near neutral pH of about 7. The
near neutral pH of the mature melanosome is thought to provide a favorable environment for
tyrosinase (TYR), the rate-limiting melanin synthesizing enzyme[142-144]. The change in pH
during melanosome maturation is thought to be controlled by several membrane proteins[137]
(e.g., OCA2, SLC45A2, and TPC2/TPCN2) (Figure 15). OCA2 and SLC45A2 are presumed to
be positive pH regulators, while TPC2 is considered to be a negative pH regulator. Based on the
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proposed role of positive and negative pH regulators (Figure 14), we anticipated that these
proteins have different pH profiles of stability and activity. In addition, there are other
melanosome proteins important for melanin synthesis (e.g., the ATP7A protein, which is altered
in individuals with Menkes disease, and which supplies Cu2+ to the melanosome for TYR
catalytic activity) that may exhibit pH-dependent stability and activity. It can be expected that
the ATP7A protein, which supplies copper to TYR, should have a similar pH-dependence on
activity as compared to TYR[145, 146].

Figure 15. Schematic representation of the multistage processes of melanosome formation and
proteins participating in pH regulation and melanin synthesis. The characteristic pH for each
melanosome stages are indicated in the figure as well.

We anticipate that OCA2 and SLC45A2 have maximal activity at acidic pH, while TPC2
has maximal activity at basic pH. OCA2 plays a major role in human lighter skin and hair
pigmentation and blue vs brown eye color variation[147] and regulates melanosomal pH and
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maturation[147-149]. It may also be involved in small molecule transport for the biosynthesis of
melanin[150, 151]. SLC45A2 also acts as a melanocyte differentiation agent and participates in
the transport of substances required for melanin biosynthesis[149, 152, 153]. TPC2 affects
pigmentation by regulating melanosome pH and size by mediating Ca2+ release from the
organelle[154, 155].
Thus, understanding how melanosomal pH affects the activity of these proteins is
essential. Furthermore, these proteins are commonly mutated in disease and those variants may
impact the normal pH-optimum of these proteins. Predicting pH-optimum of activity is not an
easy task and requires modeling of the details of the corresponding biochemical reactions as a
function of pH. Here, we take advantage of the observation that pH-optima of activity and
stability typically are the same as indicated in our earlier work[156]. Thus, our goal is to
computationally determine the pH-dependence of stability of OCA2, SLC45A2, TPC2, TYR,
and ATP7A proteins. Furthermore, we analyze the effects of common pigmentation and disease
associated variant alleles in these proteins on the pH-dependence of their stability.

5.2 Results

As pointed earlier, in this work we focus on several proteins participating in melanosome
formation, with the goal to contrast their stability pH-dependence and the effect of pathogenic
variants. We use the observation made in our previous work that pH-optimum of activity is
correlated with the pH optimum of stability[29]. This allows us to speculate that the results
obtained on stability can be inferred to activity of these proteins. We present the results according
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to the classification of the proteins as “positive” and “negative” regulators and probe our
hypothesis that “positive” regulators should have lower pH-optimum as compared with
“negative” regulators. Firstly, we present the results of the wild type proteins and sequentially
the results about the mutants.

5.2.1 pH dependence of folding free energy on wild type proteins
For each wild type protein, the magnitude of the “constant” in equation (2) is unknown,
because there is no experimental data of the folding free energy at a given pH for any of the
proteins modeled in this work. Because of that it was set to be zero at the beginning of the
simulated pH interval, pH=4.0. Here we present the calculated pH-dependence of the folding
free energy using energy minimized structure (Figure 16) and we averaged results over 20 snap
shots taken from MD simulations (Figure 25, Appendix C). We do not focus heavily on the
results obtained with MD snap shots because DelPhiPKa was developed to calculate pKa’s of
ionizable groups using static structures. However, we probe the sensitivity of the results using
MD snap shots to investigate the role of plausible conformational changes on the pH-dependence
of stability. We see no significant difference of the results obtained with energy minimized
structure and averaged results over 20 snap shots which suggests that there are no structural
changes contributing to the stability pH-dependence.
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Figure 16. The pH-dependence of the folding free energy of wild type proteins from minimized
structures within pH range 4-8.

TYR has the highest pH-optimum of stability, the pH-optimum about 8.0 or higher
(Figure 16). In contrast, OCA2 protein (the positive regulator protein) has the lowest pHoptimum of stability, pH-optimum about 5.0 – 6.0. The other positive regulator, the SLC45A2
protein, also has pH-optimum lower that neutral pH, pH-optimum of 6.5. Presumed negative
regulator TPC2 and the ATP7A protein which supplies copper to TYR both have pH-optima
close to neutral pH. Thus, there is distinctive pH difference of the stability of OCA2, SLC45A2,
TYR, ATP7A, and TPC2. Furthermore, the modeling confirms the experimental observation that
TYR is most active at neutral pHs and with reduced activity at acidic pHs[144].
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The origin of pH-dependence of the folding free energy is the difference of the pKa’s of ionizable
groups in folded and unfolded state. Thus, if the pKa’s in folded and unfolded states are the same,
there will be no pH-dependence. Furthermore, even if they are different but are outside the pH
region of interest, the pH-dependence of the folding free energy will be affected as well. It is not
expected that the pKa’s of titratable groups in the unfolded state will be perturbed from standard
pKa values[157], and thus most of the pH-dependence of the folding free energy should originate
from perturbed pKa’s in folded state. However, for completeness, in Claculated PKa’s

(Appendix C), we provide the calculated pKa’s for both states, folded and unfolded. Indeed,
one can see that for “positive” regulators most of perturbed pKa’s are for acidic groups, thus
resulting in pH-dependence at low pH. In contrast, most of perturbed pKa’s for TYR, ATP7 and
the “negative” regulator TCP2 are of His residues, resulting in pH-dependence at neutral pH.

5.2.2 Effect of pathogenic variants on protein stability
Error! Reference source not found.. shows the average change of folding free energy due
to variants based on predictions made using the methods described above. The low standard
deviations reported reflects the consistency of results obtained with different tools. Most of the
variants appear to destabilize the proteins by a modest amount. However, some mutants, such as
A481T and N489D in OCA2, C1002F and I1264V in ATP7A, are predicted to significantly effect
protein stability. In the case of OCA2 A481T and N489D variants, both of which have been
observed among individuals with albinism, the predicted large change of the folding free energy
can be attributed to the change of the physio-chemical properties of the wild type residues: A→T
and N→D. A→T representing a hydrophobic to polar residue change, while N→D represents a
polar to charge residue change. In contrast, C1002F (and I1264V in ATP7A are conservative
variants but are also predicted to result in a large change of the folding energy. In this case, the
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change in folding energy is thought to be caused by the distortion of the residue packing caused
by the different geometries of the side chains [158]. The structure of the proteins with variant
sites mapped are provided in Figure 17.

Figure 17. 3D structures with variants (shown in red color): (a) TYR; (b) OCA2; (c) TPC2; (d)
SLC45A2; (e) ATP7A

Table 2. Change in folding free energy due to variants
Change in folding free energy (∆∆G) due to variants(kcal/mol)
Protein

variant

Avg ∆∆G

SD

TYR

R402Q

-0.5

0.5

S192Y

-0.27

0.78

Double MT*

-0.77

1.09
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OCA2

SLC45A2

TPC2

ATP7A

A481T

-1.01

0.52

H615L

0.17

0.39

N489D

-1.05

1.08

P743L

-0.9

0.45

R419Q

-0.54

0.33

V443I

-0.54

0.48

G198V

-0.51

0.25

L374F

-0.84

0.47

K376R

-0.49

0.3

M484L

-0.86

0.33

M546I

-0.1

0.67

V219I

-0.11

0.32

C1002F

-1.2

0.74

G666R

-0.21

0.7

D1044E

-0.8

0.53

I1264V

-1.1

0.74

K742R

0.01

0.35

M1311V

-0.79

0.35
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R844C

-0.48

0.39

S653Y

-0.45

0.54

Note: Positive and negative sign of ∆∆G represents stabilization and destabilization due to variant respectively.
* indicates double mutants (R402Q and S192Y) for TYR and ∆∆G is calculated by taking sum of individual changes.

Overall, the predicted changes of the folding free energy are not extremely large,
however, since we do not know the absolute folding free energy of the proteins and how the
change in protein stability affects the activity, it is impossible to assess how these moderate
changes affect protein activity. However, we can reasonably assume that the activity will
decrease when folding free energy changes, even when the variants appear to make the protein
more stable (e.g., H615L in OCA2 protein), because in most cases any significant deviation of
wild type properties is deleterious for protein function[66, 67].

5.2.3 pH dependence of folding free energy on mutants
We compared the effect of non-synonymous variants on the pH-dependence of protein
stability of the wild type and corresponding variant proteins using both free energies minimized
structures (Figure 18) and snap shots generated via MD simulations (Figure 26, Appendix C).
One can see that there is no significant difference in the results obtained with different protocols.
As mentioned in the method section, we considered that the “constant” in equation 2 is the
predicted folding free energy change caused by the variants (Error! Reference source not
found.). The most drastic effects were found for OCA2, whereas the variants in other proteins
have moderate effects on the pH-dependence of folding free energy. In the case of OCA2, most
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of the variants (except one, H615L) were predicted to alter the pH-dependence of stability
suggesting that the variant protein will be less stable at neutral pHs.

Figure 18. The pH-dependence of the folding free energy of wild type proteins and their mutants
from minimized structures within pH range 4-8.

Furthermore, many variants in OCA2 (R419Q, N489D and V443I) result is a shift of pHoptimum to lower pH. This will result in a shift of maximal activity of OCA2 towards the lower
pH range and could result in a shift in the balance between positive and negative regulators such
that the resulting pH set point will be lower that the wild type melanosome. Low pH in the
melanosome in turn will result in reduced TYR activity.
The above observations focused on the shape of the pH-dependence curve of folding free
energy without considering the magnitude of the change. It should be mentioned that the changes
in the folding free energy of OCA2 are within several kcal/mol, while the changes of the pH-
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dependence of folding free energy caused by variants in other proteins are sometimes larger
(Figure 18). Despite this, the predicted changes in the stability will likely affect protein activity
and alter the balance of pH in melanosome.
The reason why variants in OCA2 have significant effects on the pH-dependence of
folding free energy can be found in Table S1. Our study focuses on the pH interval 4.0 to 8.0
and the pH-dependence is induced by titratable groups that have different pKa values in folded
versus unfolded state. Such titratable groups are Asp, Glu and His. One can see that in the case
of OCA2, variants result in perturbed pKa’s of Glu and Asp, while having almost no effect on
pKa’s of His. This is the reason why the pH-dependence of the folding free energy of OCA2 is
mostly affected over acidic pHs.

5.3 Discussions

We studied the effect of coding variants[149] of melanosome proteins on protein stability
and the pH-dependence of their folding free energy. In TYR, both variants (R402Q and S192Y)
individually do not affect pH-dependence, because they either do not involve titratable groups
or involve titratable groups with very high pKa, outside the pH interval of the study. Of note, a
single haplotype allele in which these two alleles, R402Q and S192Y, are found together in cis
has been suggested to present as a pathogenic haplotype for OCA1[159] . Therefore, we
examined whether the presence of both variants affected protein stability; TYR modeled with
both variants had modest change in protein stability (Error! Reference source not found.). In
the case of ATP7A, modest changes of the pH-dependence caused by variants are predicted to
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occur at neutral and higher pHs. Overall, the changes of stability are quite small. The reason for
modest changes in the stability and little effects on the pH-dependence can be attributed to the
conservative nature of the variants. In all cases, the physio-chemical properties of wild type sites
are preserved. Considering SLC45A2, both variants do not involve titratable groups and do not
cause alteration of the wild type pH-dependence of the folding free energy. However, significant
change of the protein’s stability is predicted which would affect SLC45A2 function. Significant
alterations of pH-dependence of the folding free energy caused by variants are predicted for the
OCA2 protein. Indeed, most of the variants alter the wild type physio-chemical properties of the
protein. As a result, all variants have a shifted pH-optimum shifted from the wild type OCA2
pH-optimum. Lastly, the variants in TPC2 do not cause significant changes of either stability or
pH-dependence of the folding free energy.
Our data suggests that variants predicted to be pathogenic (e.g., OCA2: N489D, V443I)
likely function by affecting protein stability and/or pH-dependence of folding free energy, our
data also identifies known variants with conflicting interpretations/unknown significance (e.g.,
OCA2: A481T, R419Q) that may affect protein stability and/or pH-dependence of folding free
energy. OCA2*R419Q is thought to modify the penetrance of the OCA2 locus and may affect
the risk of melanoma[160]; therefore, our data suggest that melanosomal pH may have a
functional role in melanoma genesis. These variants require biological testing to prove this
association. However, our analysis failed to find any pH or protein stability effects of variants
predicted to be pathogenic (e.g., TYR: R402Q; OCA2: P743L; or ATP7A: G666R). Thus, it is
not a foregone conclusion that variants in protein coding sequences affect protein stability and/or
pH-dependence of folding free energy suggesting other mechanisms of protein inactivation
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occur. The TPC2 variants (K376R, M484I and V219I) are conservative variants and their
identification by GWAS may reflect these variants may reside in LD with other variants or
structural alleles, that impact expression, protein stability or function. Furthermore, SLC45A2
(rs16891982 = L374F) was a top SNV associated with altered SLC45A2 mRNA expression
levels and may be mediating GWAS association via this mechanism [161]. Given the uncertainty
of variant associations with function, our data suggests that assessing the function of protein
variants on a large scale by structural modeling may be helpful. Perhaps, the addition of a pH
polygenic score that takes into consideration the pH impact on the melanosome and all of its
channels and enzymes will help in the assignment of variants to predicted functional groups.
5.4 Materials and Methods

The method section consists of four components: (1) obtaining 3D structures of the proteins
of interest; (2) generation of mutants in silico; (3) molecular dynamics simulations; and (4)
calculating pH-dependence of the folding free energy.

5.4.1 Structures used in the modeling
TYR protein: The 3D structure of TYR was modeled using SWISS-MODEL[162] from an
amino acid sequence of length (529 aa) taken from UniProt (ID: P14679)[114]. A template (PDB
ID: 5M8P)[163] with percentage identity of 44 percent and covering 81 percent (19-452) of total
sequence of TYR was selected. The corresponding model and template are shown in Figure 19.
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Figure 19. 3D model of TYR: (left) 3D structure of TYR; (right) superimposition of the TYR
model (green) with its template (red)

OCA2 protein: The 3D structure of OCA2 was modeled using Phyre2 [164]. The full
length sequence of OCA2 is 838 aa and is taken from UniProt (ID: Q04671)[114]. A template
(PDB ID: 4F35)[165] was selected with percentage identity of 20 percent to query and covering
60 percent of the sequence of OCA2 (Figure 20). The helical content was well preserved between
the template and the model (Figure 20).
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Figure 20. 3D model of OCA2: (left) 3D structure of OCA2; (right) superimposition of the OCA2
model (cyan) with its template (red)

TPC2 protein: A crystal structure for TPC2 is available (PDB ID: 6NQ2)[166] and is a
homodimer with 752 residues (Figure 21).
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Figure 21. 3D model of TPC2: (blue) monomer A; (green) monomer B

SLC45A2 protein: The 3D structure of SLC45A2 was modeled using Phyre2 [164]. Its
sequence was taken from UniProt (ID: Q9UMX9)[114] with a sequence length of 530 amino
acids. The chosen template (PDB ID: 4YBQ) [167] covers 94 percent of the sequence with
identity of 14 percent (Figure 22).
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Figure 22. 3D model of SLC45A2: (left) 3D structure of SLC45A2; (right) superimposition of
the SLC45A2 model (cyan) with its template (red)

ATP7A protein: The 3D modelling of this protein was also done by using Phyre2 [164]
. The sequence was taken from UniProt (ID: Q04656)[114] with a sequence length of 1500 amino
acids. The template (PDB ID: 3RFU)[168] covers 57 percent of the sequence (646-1411) with
identity of 41 percent (Figure 23).
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Figure 23. 3D model of ATP7A: (left) 3D structure of ATP7A; (right) superimposition of the
ATP7A model (green) with its template (red)

5.4.2 List of non-synonymous GWAS identified pigmentation associated variants
The NHGRI-EBI catalog of human genome-wide association studies (GWAS)[169] was
queried April 4th, 2020 to identify all non-synonymous variants in genes TYR, OCA2, SLC45A2
TPCN2 and ATP7A found associated with common human pigmentation variation of skin and
hair (see Error! Reference source not found.).
Of note the variants identified by GWAS are associations. In the case of non-synonymous
coding variants, they may impact protein function or alternatively they may, like those
associations identified in non-coding regions of the genome, be in tight linkage disequilibrium
(LD) with other variants that may function to impact expression levels or proper splicing. These
studies are important as they measure the impact of protein variation on the pH-dependence of

65

the folding free energy and can help to establish whether a variant directly impacts the protein
in question.
5.4.3 Generation of mutants
To generate 3D structure of protein variants while avoiding the introduction of artificial
errors, we used the model of the wild type protein and the corresponding residue was mutated
using UCSF Chimera[85]. The folded wild type structures and variant sites mapped onto a 3D
structure of folded TYR, OCA2, TPC2, and ATP7A are shown in Figure 17. One can see
(sequence alignment, Appendix C) that most of the variants are within well preserved structural
regions, away from the loops, which reduces the uncertainty of the 3D modeling.
5.4.4 Molecular dynamics (MD) simulations
MD simulations were performed under periodic boundary conditions using NAMD2.9[82]
with atomic parameters of the CHARMM forcefield[170]. The protein structures were prepared
for the simulations using VMD[86] and TIP3P water molecules were applied to build the explicit
water solvated systems. Finally, the neutralized system with NaCl were added wherever
neutralization was needed.
Simulations were performed for 20 ns for each protein structure with different initial atomic
velocities. In the production stages of the simulations, they were equilibrated under constant
volume−temperature (NVT) conditions for 100 ps followed by 2000 ps (= 2 ns) of constant
pressure−temperature (NPT) equilibration at 1 atm pressure and 310 K (with the same restraints).
The first 15 ns of the simulations were not equilibrated, so they were removed. The structural
analysis was sampled from the last 5 ns at every 250ps. This produced 20 snapshots per structure;
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all of them were subjected to DelPhiPKa[41, 171, 172] calculations after removing the explicit
water molecules.
5.4.5 Modeling pH-dependence of folding free energy
To model the pH-dependent folding free energy, we built a 3D model of the unfolded
state[157]. The unfolded structure ensembles of the wild type proteins were generated using the
“flexible meccano” approach[173, 174] and among them we selected one representative structure
(the structure with no helices and strands) (Figure 24). The unfolded mutants were then generated
by using UCSF Chimera[85].

Figure 24. Unfolded structure of wild type proteins
The pKa’s and net charge of the wild type protein and mutants, both in the folded and
unfolded states, were calculated using DelPhiPKa[41, 171, 172]. We also calculated the pKa’s
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and net charge for each of the 20 snapshots taken from the MD simulation to obtain the average
net charge and its difference with respect to wild type proteins.
The change in folding free energy (ΔΔG

folding

) was calculated from the net charge

difference between the folded state and the unfolded state, taking the unfolded state as the initial
state. The following equation is used over the pH-range of interest, giving an explicit pHdependent form of the folding free energy [29, 175].

∆∆𝐺 𝑓𝑜𝑙𝑑𝑖𝑛𝑔 = 2.3𝑘𝑇 ∑ ∆𝑞𝑑𝑝𝐻 + 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡

(2)

where, ∆𝑞 is the change of net charge from unfolded to folded state and 𝑑𝑝𝐻 is the pH interval.
The constant is the absolute folding free energy at a given pH.
For the analysis of the wild type proteins, the “constant” was considered to be zero at the
beginning of the pH interval because there is no information about the absolute folding free
energy of the individual proteins and predicting it would introduce significant and unwanted
noise. However, for the mutants, there are many algorithms that are benchmarked against
experimental data and shown to perform well, and this gives us the opportunity to predict the
change of the folding free energy caused by variant with acceptable confidence. Thus, for the
mutants, the “constant” was considered to be the free energy difference between wild type and
mutant proteins caused by the variant. The folding free energy changes were modeled using an
in-house algorithm, the SAAFEC-SEQ[44] method, along with third party tools such as
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INPS3D[176], INPS-SEQ[176], mCSM[123], SDM[124], DUET[121], I-Mutant-SEQ[125],
MUpro-SEQ[177], iStable-SEQ[178] and DeepDDG[179].

5.5 Conclusions

The importance of melanosomal pH for the regulation of organelle maturation is well
studied[150, 154], but how the melanosomal proteins regulate the desired pH remains unknown.
The same applies for their genetic variants[154]. Here we suggest a mechanism of competitive
pH-dependence of stability and activity of “positive” and “negative” pH regulators. Our data
suggests that the “positive” regulators of melanosomal pH should be having maximal activity
(and thus maximal stability) at low pH, while the opposite is expected from “negative”
regulators. Indeed, we have shown that OCA2 and SLC45A2 have low pH-optimum as
compared to TPC2 protein. Furthermore, the TYR and its partner ATP7A are also shown to have
a pH-optimum at neutral and higher pHs. We predict that similar mechanisms of pH regulation
can be expected for other melanosomal proteins.
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Tables for chapter four

Table 3. Summary of annotation of the 19 variants from COSMIC database. This consists of insilico prediction scores that is used by combinatory approach to make our pathogenicity
classification. We also have GERP++ score that shows higher rates of evolutionary conservation
for pathogenic variants compared to the benign.

AA
Polyphe LRT
Mutati n2
on
S606C 0.965
0.024

Meta
SVM

VEST3

PROVEAN

REVEL

Eigen

CADD

Our Prediction GREP++ gnomAD Clnsig

1.062

0.437

-2.320

0.565

4.351

25.9

Pathogenic

4.57

.

.

S606Y 0.948

0.024

1.064

0.451

-1.770

0.578

4.324

26.8

Pathogenic

4.57

.

.

L605V 0.821

0.000

1.042

0.178

0.070

0.365

2.095

22.8

Benign

4.57

.

.

M563I 0.932

0.000

1.069

0.826

-3.060

0.883

5.017

29.5

Pathogenic

4.48

.

.

K562M 0.998

0.000

1.042

0.788

-4.930

0.858

5.063

29

Pathogenic

4.48

.

.
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P534A 0.849

0.723

0.772

0.144

-0.720

0.318

2.038

6.224

Benign

2.34

.

T530I 0.011

0.148

0.551

0.048

-1.800

0.296

0.519

5.558

Benign

2.63

4.035E-06 .

R490Q 0.988

0.000

1.045

0.521

-0.340

0.622

4.880

27.1

Pathogenic

4.54

.

.

Q398E 0.001

0.052

0.165

0.157

0.520

0.351

1.187

3.064

Benign

3.89

.

.

A289E 0.994

0.000

1.079

0.967

-2.700

0.967

6.548

29.7

Pathogenic

4.24

.

.

L272R 1.000

0.000

1.044

0.979

-5.100

0.954

6.031

30

Pathogenic

4.39

.

.

S258L 0.979

0.000

1.063

0.974

-3.100

0.913

6.209

27.1

Pathogenic

4.80

.

VUS

V220M 0.896

0.002

1.088

0.785

-1.820

0.799

3.983

24.4

Pathogenic

4.80

.

VUS

H204Y 0.975

0.000

1.054

0.911

-5.020

0.969

8.195

27.4

Pathogenic

4.76

.

.

E200K 0.985

0.000

1.053

0.954

-3.550

0.948

7.484

34

Pathogenic

4.76

.

.

C170Y 0.995

0.000

1.029

0.979

-9.330

0.953

7.550

29.3

Pathogenic

4.8

.

.

R108P 0.700

0.000

1.081

0.668

-1.280

0.655

4.143

25.4

Pathogenic

5.02

.

.

L89R 0.998

0.000

1.036

0.996

-4.640

0.923

6.063

24.5

Pathogenic

5.02

.

.

L36F

0.000

1.048

0.826

-2.540

0.901

5.751

26.8

Pathogenic

4.89

.

0.994

.

*Clnsig: Clinical Significance from ClinVar Database
*VUS: Variant of Unknow Significance

Table 4. Calculation of Folding Free Energy Change (kcal/mol) of variants from COSMIC &
VariSNP database. The calculated folding free energy changes in kcal/mol of menin protein due
to mutations from COSMIC and VariSNP database. The positive value indicates destabilization
and negative value indicates stabilization.
AA
Mutation

Our
Prediction

SAAFEC

mCSM

SDM

DUET

CUPSAT

I-Mutant

Average

Missense Variants from COSMIC DB
S606C

Pathogenic

2.23

0.27

-0.75

-0.20

-0.73

2.18

1.56

S606Y

Pathogenic

0.29

0.43

-0.54

0.16

0.95

0.51

0.47

L605Y

Benign

-2.53

0.48

0.6

0.52

0.53

-0.03

0.53

M563I

Pathogenic

-1.08

1.10

0.32

0.68

-1.18

-0.48

-0.91

K562M

Pathogenic

5.90

-0.48

0.06

0.56

-0.01

-0.23

2.13

P534A

Benign

2.57

0.27

-0.69

-0.11

1.62

0.98

1.36

T530I

Benign

0.23

0.16

-1.31

-0.41

2.97

0.11

0.87

R490Q

Pathogenic

2.50

0.67

0.32

0.59

-0.61

0.56

0.93

Q398E

Benign

2.07

0.03

-0.97

-0.46

1.25

-1.44

1.12

A289E

Pathogenic

11.39

2.71

2.97

3.04

2.94

0.75

3.96

L272R

Pathogenic

-4.26

2.30

3.02

2.36

5.55

0.51

2.75
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S258L

Pathogenic

1.80

0.03

-0.22

-0.18

1.7

0.95

1.12

V220M

Pathogenic

-0.65

0.75

0.14

0.57

2.2

2.15

1.16

H204Y

Pathogenic

-1.42

-1.32

-0.02

-1.35

-1.52

-0.25

-1.14

E200K

Pathogenic

-4.06

2.14

1.15

2.20

-4.5

0.5

1.50

C170Y

Pathogenic

-1.00

1.01

1.9

1.32

4.5

0.78

1.90

R108P

Pathogenic

6.49

0.31

2.23

0.87

0.71

0.81

1.90

L89R

Pathogenic

-2.33

1.54

1.76

1.47

5.16

2.1

2.41

L36F

Pathogenic

1.17

1.51

1.39

1.77

2.02

0.84

1.45

VariSNP Benign Variants
P519S

Benign

1.00

0.95

-0.72

0.47

-2.93

1.43

0.96

V555L

Benign

-2.58

0.63

0.86

0.45

0.41

0.35

0.54

I377T

Benign

-0.99

2.46

3.46

2.80

4.46

4.18

3.47

E371D

Benign

-4.08

1.04

1.39

1.04

0.31

0.81

0.92

G508D

Benign

-0.88

0.40

-0.26

-0.06

0.53

1.34

0.76

Table 5. Calculation of Folding Free Energy Change (kcal/mol) of variants from ClinVar
database. The calculated folding free energy change in kcal/mol of menin protein taken from
ClinVar associated with Neoplasia. The positive value indicates destabilization and negative
value indicates stabilization.
AA
Mutation
A373D
E260K
V189E
A165P
R280K
W441R
D423N
H139D

Conditions
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia

Clinical
Significance
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic

SAAFEC

mCSM

SDM

DUET

CUPSAT

Average

6.39
-3.32
5.73
0.42
1.95
-1.92
-0.98
5.81

1.93
-0.26
2.83
-0.99
0.66
2.56
1.66
0.32

3.23
0.77
3.34
4.45
0.1
1.11
0.83
1.65

2.82
-0.46
3.21
-0.25
0.46
2.21
1.59
0.49

2.25
2.13
4.24
0.17
-0.17
5.34
3.7
1.25

3.22
-1.35
3.87
1.67
0.85
2.81
1.94
1.90
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Table 6. Calculation of Binding Free Energy change of Menin-ER complex dues to COSMIC
and VariSNP mutations. The calculated binding free energy changes in kcal/mol of menin-ER
complex due to mutations from COSMIC and VariSNP database. The positive value indicates
destabilization and negative value indicates stabilization.
AA
Mutation

Our
Prediction

SAAMBE

BeAtMuSiC

S606C
S606Y
L605Y
M563I
K562M
P534A
T530I
R490Q
Q398E
A289E
L272R
S258L
V220M
H204Y
E200K
C170Y
R108P
L89R
L36F

Unclassified mutations from COSMIC Database
Pathogenic 0.30
-0.09
0.19
0.60
Pathogenic 0.29
0.05
-0.04
0.55
Benign
0.29
0.01
-0.24
0.62
Pathogenic 0.39
0.25
0.49
1.75
Pathogenic 0.52
0.15
0.25
1.05
Benign
-0.27
0.13
0.59
-0.24
Benign
0.20
0.09
-0.01
0.51
Pathogenic 0.37
0.25
0.11
0.75
Benign
0.42
0.07
0.14
0.47
Pathogenic 0.57
0.68
-0.55
2.63
Pathogenic 0.34
0.92
0.38
2.00
Pathogenic 0.40
0.53
0.21
1.53
Pathogenic 0.26
0.19
-0.22
0.71
Pathogenic 0.34
0.38
0.32
0.44
Pathogenic -0.24
0.39
0.77
0.90
Pathogenic 0.57
0.23
-0.34
2.75
Pathogenic 0.70
0.16
1.08
1.27
Pathogenic 0.54
0.48
0.20
1.16
Pathogenic 0.29
0.34
0.43
1.55
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mCSMPPI2

MutaBind

Average

0.37
0.30
0.31
0.72
0.50
0.36
0.27
0.45
0.28
1.30
0.91
0.67
0.39
0.37
0.69
1.18
0.80
0.60
0.73

P519S
V555L
I377T
E371D
G508D

Benign
Benign
Benign
Benign
Benign

Benign mutations from VariSNP Database
-0.22
-0.37
-0.16
0.40
0.22
0.15
0.27
1.27
0.10
0.22
0.19
-0.13
0.70
0.33
-0.27

-0.43
0.49
1.53
1.68
0.75

-0.29
0.32
0.79
0.70
0.59

Table 7. Calculation of Binding Free Energy change of Menin-MLL complex dues to COSMIC
and VariSNP mutations. The calculated binding free energy changes in kcal/mol of menin-MLL
complex due to mutations from COSMIC and VariSNP database. The positive value indicates
destabilization and negative value indicates stabilization.
AA
Mutation

Our
Prediction

SAAMBE

S606C
S606Y
L605Y
M563I
K562M
P534A
T530I
R490Q
Q398E
A289E
L272R
S258L
V220M
H204Y
E200K
C170Y
R108P
L89R
L36F

Pathogenic
Pathogenic
Benign
Pathogenic
Pathogenic
Benign
Benign
Pathogenic
Benign
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic

0.24
0.44
0.34
0.39
0.43
0.09
0.30
0.44
0.41
1.00
0.86
0.18
0.25
0.73
0.49
0.75
0.78
0.86
0.71

P519S

Benign

0.01

BeAtMuSiC

mCSM-PPI2

COMSIC Mutations
-0.09
0.19
0.05
-0.01
0.01
-0.17
0.25
0.45
0.05
0.24
0.2
0.47
0.09
-0.03
0.25
-0.06
0.07
-0.18
1.02
-0.70
0.88
0.32
0.64
0.23
0.19
0.23
0.29
-0.05
0.39
0.84
0.23
-0.34
0.16
1.04
0.48
0.18
0.34
0.37
VariSNP Mutations
-0.37
-0.14
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MutaBind

Average

0.76
0.70
0.55
1.59
0.99
-0.19
0.56
0.91
0.36
2.20
2.35
1.32
0.57
1.12
1.42
2.67
1.16
1.17
1.36

0.40
0.41
0.30
0.67
0.43
0.25
0.32
0.53
0.28
1.40
1.10
0.59
0.31
0.71
0.78
1.22
0.78
0.67
0.71

-0.19

-0.18

V555L
I377T
E371D
G508D

Benign
Benign
Benign
Benign

0.60
0.50
0.29
0.64

0.22
0.99
0.27
0.33

0.16
0.17
0.28
-0.19

0.74
1.73
0.77
1.06

0.43
0.85
0.4
0.68

Table 8. Calculation of Binding Free Energy change of Menin-ER complex dues to ClinVar
mutations. The calculated binding free energy changes in kcal/mol of menin-ER complex due to
mutations from ClinVar. The positive value indicates destabilization and negative value indicates
stabilization.
AA
Mutation

Conditions

Clinical
Significance

SAAMBE

BeAtMuSiC

mCSMPPI2

A373D
E260K
V189E
A165P
R280K
W441R
D423N
H139D

Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia

Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic

0.58
0.08
0.53
0.68
0.08
-0.74
0.12
0.51

1.29
0.30
1.92
1.24
0.15
1.23
0.16
0.51

-0.61
0.64
0.21
0.18
0.16
1.83
0.98
0.34

MutaBind

2.26
0.90
2.06
2.90
0.31
2.33
1.20
1.63

Averag
e
1.38
0.56
1.18
1.25
0.18
1.80
0.62
0.75

Table 9. Calculation of Binding Free Energy change of Menin-MLL complex dues to ClinVar
mutations. The calculated binding free energy changes in kcal/mol of menin-MLL complex due
to mutations from ClinVar. The positive value indicates destabilization and negative value
indicates stabilization.
AA
Mutation
A373D
E260K
V189E
A165P
R280K

Conditions
Neoplasia
Neoplasia
Neoplasia
Neoplasia
Neoplasia

Clinical
Significance
Pathogenic
Pathogenic
Pathogenic
Pathogenic
Pathogenic

SAAMBE

BeAtMuSiC

0.21
0.40
0.30
0.58
0.25

0.78
0.39
1.92
1.20
0.06
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mCSMPPI2
-0.65
0.68
0.40
0.17
0.30

MutaBind

Average

2.11
1.20
2.3
2.5
0.30

1.03
0.67
1.23
1.11
0.23

W441R
D423N
H139D

Neoplasia
Neoplasia
Neoplasia

Pathogenic
Pathogenic
Pathogenic

0.53
0.63
1.70

1.01
0.23
0.79

0.55
0.74
0.75

2.79
1.43
1.84

1.22
0.76
1.27

Table 10. KNN Classification Results of the 19 mutations from COMSIC database. The training
dataset was constructed using well curated mutations from ClinVar and VariSNP. The features
used for this supervised learning method is evolutionary conservation score (GERP++) and
folding energy change (ΔΔG). And with a K=5 we were able to classify at a higher accuracy.
ΔΔG

AA
Change

GERP++

S606C

4.57

1.56

S606Y

4.57

A289E

Combinatory
Insilco Prediction

KNN Classification Features
ΔΔG

P

GERP++ and
ΔΔG
P

0.47

P

P

B

4.24

3.96

P

P

P

L272R

4.39

2.75

P

P

P

S258L

4.8

1.12

P

P

P

V220M

4.8

1.16

P

P

P

H204Y

4.76

-1.14

P

P

B

Q398E

3.89

1.12

B

P

B

L605V

4.57

0.53

B

P

B

M563I

4.48

-0.91

P

P

B

K562M

4.48

2.13

P

P

P

P534A

2.34

1.36

B

B

B

T530I

2.63

0.87

B

B

B

R490Q

4.54

0.93

P

P

P

E200K

4.76

1.5

P

P

P

C170Y

4.8

1.9

P

P

P

R108P

5.02

1.9

P

P

P
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P

L89R

5.02

2.41

P

P

P

L36F

4.89

1.45

P

P

P

P* denotes Pathogenic and B* denotes Benign
*Highlighted are the difference in prediction between KNN classification and
Combinatory insilco prediction approach

Appendix C

Additional materials for chapter five

List of abbreviations
TYR- tyrosinase
OCA2- oculocutaneous albinism 2
SLC45A2- solute carrier 45 member 2
TPC2- two-pore channel 2
ATP7A- copper-transporting ATPase 1
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Figures from the result of MD snapshot

Figure 25. The pH-dependence of the folding free energy of wild type proteins from 20 MD snap
shots within pH range 4-8.
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Figure 26. The pH-dependence of the folding free energy of wild type proteins and their mutants
from 20 MD snapshots within pH range 4-8.

Sequence alignments :
Sequence alignment of all the models with its template by using T-Coffee web server
[180] are shown below. An asterisk (*) indicates positions which have a single, fully conserved
residue; a colon (:) indicates conservation between groups of strongly similar properties; a period
(.) indicates conservation between group of weakly similar properties.
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Figure 27. Sequence alignment of TYR with percentage identity of 44 percent with its template,
E-value=0 and Score=920.38
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Figure 28. Sequence alignment of ATP7A with percentage identity of 47 percent with its
template, E-value=0 and Score=1181.05
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Figure 29. Sequence alignment of OCA2 with percentage identity of 20 percent with its template,
E-value=0 and Score=388.81
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Figure 30. Sequence alignment of SLC45A2 with percentage identity of 14 percent with its
template, E-value=4.4e-26 and Score=153.21
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Claculated PKa’s

Table 11.Calculated pKa’s for the folded and unfolded structures.

TYR

Folded/Unfolded

ResName

WT

S192Y

R402Q

ASP0042P

3.38/3.71

3.72/3.71 3.49/3.71

ASP0075P

2.22/3.77

2.42/3.77 2.52/3.77

ASP0076P

2.45/3.99

3.19/3.99 3.1/3.97

ASP0125P

3.57/3.33

3.32/3.33 3.47/3.32

ASP0132P

3.58/3.78

3.71/3.78 3.58/3.77

ASP0148P

3.19/2.97

3.49/2.97 3.57/2.96

ASP0169P

3.76/3.88

3.47/3.88 3.15/3.88

ASP0174P

2.56/3.68

2.84/3.67 2.67/3.72

ASP0186P

2.95/3.49

3.43/3.49 3.09/3.53

ASP0197P

3.54/3.83

3.59/3.83 2.99/3.81

ASP0199P

3.51/3.54

2.32/3.54 1.92/3.54

ASP0228P

3.03/3.41

2.65/3.41 3.45/3.4

ASP0237P

3.36/3.83

2.43/3.83 2.36/3.85

ASP0240P

3.38/3.94

2.27/3.95 2.99/3.93

ASP0245P

2.84/3.35

3.42/3.35 3.58/3.32

ASP0249P

3.54/3.58

3.5/3.58

3.5/3.54
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ASP0305P

3.56/3.54

3.49/3.54 3.28/3.52

ASP0317P

3.34/3.86

3.42/3.86 3.34/3.86

ASP0333P

2.59/3.05

3.41/3.06 2.82/3.04

ASP0356P

3.75/3.96

3.44/3.97 3.68/3.96

ASP0383P

2.03/3.76

2.25/3.76 2.27/3.76

ASP0394P

2.19/3.78

2.25/3.78 2.23/3.79

ASP0437P

3.16/3.41

2.52/3.41 2.53/3.41

ASP0444P

3.46/4.03

3.36/4.03 2.71/4.02

ASP0448P

2.83/3.76

3.34/3.76 3.56/3.75

ASP0454P

undet/3.79 3.24/3.79 3.58/3.79

GLU0032P 3.05/3.81

3.99/3.81 3.59/3.8

GLU0034P 3.51/3.99

3.68/3.99 3.19/3.98

GLU0078P 3.23/4.37

2.75/4.37 2.86/4.35

GLU0114P 3.76/3.64

3.79/3.64 3.68/3.64

GLU0130P 3.38/3.95

3.02/3.95 2.63/3.95

GLU0193P 3.83/3.79

4.09/3.8

GLU0203P 3.14/3.83

3.28/3.83 3.23/3.84

GLU0219P 2.57/3.39

2.72/3.39 2.7/3.38

GLU0221P 3.1/4.01

2.83/4.01 3.02/4

GLU0229P 3.8/3.9

3.05/3.9

GLU0242P 3.51/3.77

3.54/3.78 3.49/3.76

3.86/3.8

3.43/3.9
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GLU0250P 3.92/3.96

3.76/3.96 3.64/3.96

GLU0280P 3.74/3.45

3.61/3.45 3.54/3.42

GLU0281P 3.28/3.82

3.02/3.82 3.45/3.82

GLU0294P 2.97/3.05

3.44/3.05 2.94/3.05

GLU0319P 3.74/4

2.71/4

GLU0328P 2.02/3.59

2.89/3.58 2.03/3.56

GLU0345P 1.55/3.57

2.37/3.57 1.82/3.56

GLU0398P 2.09/3.85

2.08/3.85 2.53/3.98

GLU0409P 3.82/3.53

3.74/3.53 3.91/3.6

GLU0413P 3.73/3.77

3.59/3.77 3.85/3.77

GLU0423P 3.55/3.86

3.46/3.92 3.55/3.86

HIS0019P

6.33/6.5

6.38/6.5

HIS0143P

6.47/6.36

6.49/6.36 6.46/6.37

HIS0180P

5.38/6.32

5.9/6.32

HIS0202P

6.64/7.24

6.87/7.24 6.42/7.27

HIS0211P

5.9/6.38

5.95/6.38 5.71/6.38

HIS0256P

6.55/6.48

6.27/6.48 6.33/6.49

HIS0285P

6.68/6.67

6.83/6.67 6.66/6.67

HIS0304P

6.66/6.63

6.04/6.62 6.54/6.62

HIS0363P

6.04/6.5

6.39/6.5

HIS0367P

5.98/6.48

6.12/6.49 5.76/6.48

3.89/4

6.37/6.5

7.04/6.35

6.35/6.51
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HIS0389P

5.64/6.52

6.08/6.52 5.87/6.52

HIS0390P

3.59/6.5

5.29/6.5

4.35/6.51

HIS0404P

6.56/6.3

6.68/6.3

6.58/6.46

HIS0420P

6.06/6.85

6.64/6.85 6.97/6.86

TPC2

Folded/Unfolded

ResName

WT

K376R

V219I

M546I

ASP0043A

3.93/3.84 3.55/3.84 3.81/3.84 3.3/3.83

ASP0047A

3.37/3.86 3.05/3.86 3.27/3.86 2.71/3.83 3.53/3.86

ASP0055A

2.57/3.89 2.82/3.89 2.3/3.89

ASP0067A

3.04/3.75 2.95/3.75 2.84/3.75 3.04/3.75 3.25/3.75

ASP0110A

2.18/3.92 3.34/3.92 2.96/3.92 2.45/3.85 2.76/3.92

ASP0139A

2.99/3.06 2.71/3.06 3.26/3.06 2.88/2.69 3.15/3.06

ASP0171A

2.11/3.54 2.54/3.54 2.4/3.54

ASP0244A

3.54/3.63 3.53/3.63 3.92/3.63 3.48/3.58 2.83/3.63

ASP0245A

3.82/3.95 3.74/3.95 3.04/3.95 3.68/3.95 3.8/3.95

ASP0248A

3.76/3.46 3.53/3.46 3.62/3.46 3.77/3.12 3.67/3.46

ASP0276A

3.32/3.95 3.37/3.95 3.43/3.95 3.48/3.93 3.49/3.95

ASP0372A

3.14/3.24 2.99/3.22 3.23/3.24 2.99/3.23 3.14/3.24

ASP0404A

2.78/3.77 3.46/3.77 2.78/3.77 3.18/3.58 3.26/3.77

89

M484L
3.52/3.84

2.88/3.87 2.41/3.89

2.72/3.53 2.3/3.54

ASP0435A

3.23/3.89 3.49/3.89 3.03/3.89 3.11/3.87 2.71/3.89

ASP0456A

3.92/3.56 3.72/3.56 3.6/3.56

ASP0458A

3.83/3.31 3.76/3.31 3.63/3.31 2.79/3.06 3.12/3.31

ASP0465A

3.65/4

ASP0466A

3.03/4.09 3.49/4.09 3.51/4.09 3.53/3.63 3.49/4.09

ASP0505A

2.48/3.72 3.03/3.72 2.52/3.72 2.47/3.7

ASP0542A

3.28/3.79 3.38/3.79 2.43/3.79 3.16/3.77 2.05/3.79

ASP0637A

2.35/3.9

ASP0638A

1.95/3.97 2.35/3.97 2.77/3.97 2.2/3.97

3.33/3.97

ASP0660A

3.21/3.76 3.01/3.76 2.36/3.76 3.3/3.72

3.39/3.76

3.39/4

2.87/3.9

3.65/4

3.68/3.55 3.48/3.56

3.76/3.94 3.9/4

2.85/3.9

2.6/3.72

2.82/3.84 2.84/3.9

GLU0054A 2.17/3.85 2.97/3.85 2.44/3.85 3.42/3.82 2.32/3.85
GLU0100A 1.32/3.94 1.91/3.94 2.25/3.94 2.49/3.93 1.84/3.94
GLU0119A 3.85/3.54 4.02/3.54 3.95/3.54 3.92/3.5

3.97/3.54

GLU0126A 2.74/3.83 2.44/3.84 2.42/3.83 3.05/3.8

3.06/3.83

GLU0129A 1.75/3.9

1.79/3.9

2/3.9

1.98/3.87 1.93/3.9

GLU0182A 3.12/3.85 3.44/3.85 3.38/3.85 2.76/3.85 3.54/3.85
GLU0215A 3.84/3.97 3.8/3.97

3.75/3.97 3.65/3.93 3.82/3.97

GLU0250A 2.75/2.83 2.87/2.83 3.4/2.83

1.96/2.87 3.38/2.83

GLU0260A 3.7/4.1

2.95/4.07 3.72/4.1

3.59/4.1

3.74/4.1

GLU0339A 3.66/3.94 3.78/3.94 3.49/3.94 3.78/3.93 3.5/3.94
GLU0347A 3.75/3.91 4.04/3.91 3.87/3.91 3.86/3.91 3.83/3.91
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GLU0381A 3.68/3.56 2.76/3.44 3.64/3.56 3.43/3.48 2.82/3.56
GLU0394A 3.55/3.85 3.44/3.85 3.74/3.85 2.68/3.83 3.72/3.85
GLU0395A 3.7/3.46

3.53/3.46 2.45/3.46 3.67/3.43 2.94/3.46

GLU0402A 3.44/4.01 2.14/4.01 2.83/4.01 2.66/3.97 3.01/4.01
GLU0410A 3.18/3.93 3.83/3.93 2.36/3.93 3.41/3.88 3.76/3.93
GLU0416A 3.8/3.53

3.78/3.53 3.35/3.53 3.55/3.53 3.37/3.53

GLU0463A 3.87/3.62 3.89/3.62 3.68/3.62 3.74/3.44 3.8/3.62
GLU0483A 2.02/3.96 2.28/3.96 2.53/3.96 3.1/3.94

3.5/3.96

GLU0516A 3.51/3.97 3.95/3.97 3.95/3.97 3.93/3.97 3.85/3.97
GLU0533A 3.58/3.45 3.5/3.45
GLU0627A 2.8/3.97

2.91/3.45 3.78/3.2

3.49/3.45

3.44/3.97 3.49/3.97 3.02/3.96 3.78/3.97

GLU0630A 3.41/3.99 4.01/3.99 3.77/3.99 4.11/3.97 4.01/3.99
GLU0695A 2.55/4

2.66/4

2.82/4

2.65/4.01 2.47/4

HIS0064A

6.5/6.46

6.05/6.46 6.3/6.46

HIS0151A

6/6.48

5.81/6.47 5.98/6.48 5.92/6.47 5.69/6.48

HIS0181A

6.82/6.5

6.68/6.5

HIS0226A

6.22/6.73 6.22/6.73 6.02/6.73 6.17/6.73 6.28/6.73

HIS0375A

6.18/6.55 6.52/6.53 6.35/6.55 6.51/6.53 6.46/6.55

HIS0411A

6.04/6.49 5.96/6.49 5.96/6.49 6.26/6.49 6.64/6.49

HIS0431A

6.61/6.25 6.5/6.25

HIS0527A

6.65/6.49 5.82/6.49 6.66/6.49 6.62/6.49 6.47/6.49

6.71/6.5

6/6.25

6.15/6.47 6.28/6.46

6.74/6.49 6.73/6.5

6.46/6.24 6.21/6.25
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HIS0699A

5.99/6.88 6.26/6.88 6.33/6.88 5.86/6.86 5.76/6.88

SLC45A2
ResName

Folded/Unfolded
WT

G198V

I374F

ASP0093X

1.73/3.31 2.19/3.31

2.19/3.31

ASP0153X

4.16/3.82 4.2/3.82

4.2/3.82

ASP0157X

3.92/3.94 4.07/3.94

4.07/3.94

ASP0160X

2.05/3.78 2.62/3.78

2.62/3.78

ASP0169X

3.08/3.86 3.49/3.86

3.49/3.86

ASP0175X

2.87/3.19 3.25/3.19

3.25/3.19

ASP0201X

3.99/3.99 4.02/3.99

4.02/3.99

ASP0257X

3.79/3.98 3.83/3.98

3.83/3.98

ASP0263X

3.66/3.84 3.84/3.84

3.84/3.84

ASP0340X

3.69/3.7

3.7/3.7

ASP0475X

2.64/3.72 3.49/3.72

3.49/3.72

GLU0026X 3.85/3.81 3.97/3.81

3.97/3.81

GLU0046X 3.43/3.83 3.6/3.83

3.6/3.83

GLU0052X 4.41/3.74 4.46/3.74

4.46/3.74

GLU0177X 3.04/3.45 3.72/3.45

3.72/3.45

3.7/3.7
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GLU0206X 3.65/2.88 4.04/2.88

4.04/2.88

GLU0214X 4.04/3.84 4.19/3.84

4.19/3.84

GLU0239X 3.73/3.77 3.78/3.77

3.78/3.77

GLU0244X 3.62/3.82 3.79/3.82

3.79/3.82

GLU0267X 3.72/3.99 4.01/3.99

4.01/3.99

GLU0272X 2.96/3.66 3.07/3.68

3.07/3.68

GLU0368X 3.96/3.82 3.98/3.82

3.98/3.82

GLU0448X 3.2/3.64

3.68/3.64

3.68/3.64

HIS0038X

5.55/6.48 6.24/6.48

5.55/6.48

HIS0094X

6.24/6.31

HIS0173X

6.24/6.13 6.35/6.13

6.17/6.13

HIS0181X

6.03/6.26 6.36/6.26

6.3/6.26

HIS0183X

6.22/5.69 6.69/5.69

6.03/5.69

HIS0204X

6.76/6.72 6.69/6.72

6.97/6.72

HIS0233X

4.84/6.46 5.63/6.46

6.07/6.46

HIS0316X

6.22/6.33 6.73/6.33

6.25/6.33

HIS0324X

6.32/6.68

6.51/6.68 6.12/6.68

HIS0450X

6.6/6.34

5.66 /6.34 6.61/6.34

6.54/6.31 6.03/6.31
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OCA2

Folded/Unfolded

ResName

WT

V433I

R419Q

P743L

N489D

H615L

A481T

ASP0372U

3.66/3.85

3.63/3.56

3.05/3.94

3.64/3.83

3.48/3.94

3.02/3.86

3.73/3.88

ASP0384U

4.06/4.46

3.92/4.01

4.14/3.94

4.04/3.99

3.98/3.94

3.91/4.02

3.98/4.08

ASP0408U

3.54/4.03

3.19/3.53

3.56/3.93

3.44/3.79

3.36/3.95

3.74/3.84

3.56/3.77

ASP0441U

3.05/4.16

2.74/2.91

1.97/3.94

2.68/3.88

3.37/3.94

3.47/3.79

2.94/3.83

ASP0463U

2.51/3.85

2.96/2.81

2.35/3.93

2.98/3.97

2.69/3.94

2.51/4.16

2.73/3.71

ASP0486U

3.43/4.01

3.51/3.73

3.47/3.95

3.38/3.98

2.52/3.94

3.59/3.87

3/3.99

ASP0504U

3.48/4.13

3.46/3.29

3.26/4.04

3.49/3.76

3.46/3.94

3.69/3.68

3.52/3.75

ASP0601U

2.83/4.09

3.42/2.77

3.11/3.79

2.54/3.53

2.7/3.96

3.25/3.76

2.46/3.32

ASP0619U

2.99/3.73

2.2/2.81

2.86/3.89

2.98/3.89

3.22/3.94

2.87/3.64

2.35/3.83

ASP0649U

3.91/3.79

3.5/3.85

3.56/3.76

3.95/3.75

3.8/3.93

3.18/3.71

3.7/3.63

ASP0666U

4.03/4

3.79/4.1

3.98/3.93

3.97/4.3

4.04/3.94

4.07/3.46

4.02/3.44

ASP0669U

3.57/3.64

3.42/3.71

3.63/3.94

3.75/3.99

3.5/3.94

3.8/3.87

3.54/4.04

ASP0740U

3.49/3.99

3.05/4.05

3.6/4.06

2.33/3.87

3.4/3.93

2.53/3.97

3.5/3.87

ASP0758U

3.93/4.05

3.5/3.99

2.98/4.02

3.9/3.67

4.11/3.96

3.53/3.77

3.88/3.85

GLU0328U 3.77/4.19

3.9/3.54

3.06/4.01

3.5/3.87

3.57/3.92

3.57/4.01

3.48/4.03

GLU0348U 3.32/3.8

3.7/3.2

3.53/4.01

3.2/3.79

3.3/4.02

3.87/3.52

3.01/3.97

GLU0381U 3.81/4.03

3.98/3.48

3.59/4.01

3.91/4.02

3.8/4.04

3.9/3.93

3.89/4.08

GLU0386U 3.31/4.68

3.63/3.86

4.25/4.01

3.55/4.07

3.43/4

3.84/3.91

3.69/4.05

GLU0403U 3.95/4.26

3.54/3.76

3.78/4

3.62/4.17

3.92/4.02

3.65/3.85

3.6/3.96
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GLU0458U 3.35/4.09

3.73/3.96

3.4/4

3.85/3.87

3.61/4.03

3.94/4.04

3.75/3.79

GLU0471U 2.5/4.21

3.99/4.01

4.03/4.02

3.92/3.96

3.87/4

4.13/3.98

2.67/4.19

GLU0497U 3.7/3.96

3.6/3.23

3.61/4

3.24/3.97

3.81/4

3.42/3.74

3.59/3.95

GLU0540U 3.76/4.4

3.72/3.51

3.68/4.03

3.91/4

3.44/4.02

3.89/4.05

3.43/4.01

GLU0543U 3.55/4.38

3.75/3.82

2.31/4.02

3.75/3.85

3.98/4

3.78/3.84

3.76/3.26

GLU0546U 2.78/3.92

3.26/3.2

3.55/4

2.83/3.94

3.08/4

3.28/3.98

2.94/3.96

GLU0550U 3.16/3.63

2.92/3.8

3.77/4.03

3.52/3.65

2.65/4

3.62/3.78

3.56/3.71

GLU0567U 2.27/4.05

3.27/3.58

3.02/4.01

3.09/3.95

3.74/4

3.86/3.66

3.93/3.72

GLU0568U 2.25/4

4.03/3.6

3.41/4.03

3.34/3.77

2.34/4

1.89/3.43

3.94/3.49

GLU0583U 3.83/4.12

3.73/3.7

3.08/4.07

3.75/3.78

3.39/4.02

3.47/3.54

3.63/3.56

GLU0600U 3.82/4.05

2.8/3.98

2.71/4.01

3.78/4.06

3.07/4

3.79/3.42

3.73/3.55

GLU0605U 2.5/4.01

2.46/3.22

3.77/3.95

2.33/3.68

2.46/4.04

2.85/3.2

2.82/3.72

GLU0610U 3.19/3.98

3.87/3.56

3.82/3.97

2.4/3.97

2.01/4

2.87/3.8

2.43/3.84

GLU0671U 3.98/3.41

3.96/3.89

3.79/3.86

3.88/3.04

3.98/4.02

3.91/3.96

3.98/4.05

GLU0678U 3.22/4.15

2.49/3.31

3.62/3.97

3.41/3.85

3.72/4

2.99/3.82

3.55/3.94

GLU0693U 3.07/4

3.42/2.81

2.54/3.63

3.07/3.82

2.54/3.84

3/3.62

2.81/4.04

GLU0702U 3.96/4.21

4.03/3.84

3.32/3.99

3.6/4.03

4.15/3.68

3.88/4.01

3.78/3.93

GLU0706U 3.22/4.29

3.89/4.08

4.15/3.77

3.97/3.83

4.12/3.96

4.05/4.12

4.08/3.78

GLU0717U 4.05/3.56

3.91/4.05

4.08/3.92

4.06/3.83

4.15/4.04

4.01/3.95

4.01/3.82

GLU0718U 3.45/3.5

3.97/4.07

4.04/4.33

4.03/3.93

4.24/3.97

4.02/4.15

4.01/3.53

GLU0760U 3.29/3.8

3.98/4.08

3.92/3.98

3.92/4.01

3.94/3.8

4/3.99

3.8/4

95

GLU0798U 4.07/4.56

3.65/3.51

3.96/3.96

3.81/3.82

3.7/3.74

3.02/3.97

3.78/3.89

GLU0808U 1.92/3.53

1.98/1.74

2.46/6.48

1.97/3.65

1.79/3.92

2.35/3.83

2.3/3.95

HIS0351

6.4/6.64

6.2/5.97

6.1/6.48

6.1/6.62

6.3/3.76

6.2/6.82

6.5/6.5

HIS0378

6/6.85

6.9/6.62

6/6.49

6.7/6.51

6.5/6.49

6.1/6.33

6.8/6.37

HIS0511

6.8/6.53

6.3/6.66

6.4/6.49

6.5/6.55

6.6/6.49

6.9/6.39

6.6/6.26

HIS0549

6.5/6.33

6.2/6.54

6.3/6.49

6.3/6.44

6.2/6.48

6.4/6.68

6.2/6.29

HIS0552

6.2/7.12

6.3/6.44

6.3/6.5

5.8/6.81

6.5/6.49

6.3/6.37

6.4/6.8

HIS0584

6.1/6.38

6/5.6

6.3/6.49

6.3/6.37

6.1/6.49

6.5/6.67

5.7/6.52

HIS0591

6.2/6.58

6.2/5.8

6.2/6.49

5.7/5.98

6.1/6.49

6.1/5.95

6.1/6.15

HIS0594

5.9/5.82

6.2/6.01

6.1/6.27

6.3/6.51

6.2/6.49

6.1/5.83

6.6/6.58

HIS0647

6.2/6.76

6.6/7.02

6.6/7.01

6.3/6.54

6.7/6.5

6.8/6.52

6.2/6.17

HIS0668

6.8/6.9

6.9/6.76

7.1/6.72

6.6/6.72

6.5/6.49

6.8/6.38

6.4/6.54

HIS0675

6.6/6.64

6.7/6.72

6.8/6.86

6.7/6.29

6.7/6.49

6.7/6.5

6.7/6.52

HIS0697

6.6/6.59

6.6/6.76

6.7/6.55

6.6/6.21

6.8/6.18

6.7/6.64

6.7/6.26

HIS0699

6.5/6.55

6.1/7.03

6.6/6.78

6.9/6.4

7.1/6.9

6.5/6.84

6.4/6.29

HIS0757

6.7/7.22

7.1/6.59

6.7/6.67

6.8/7

7/6.51

6.7/6.53

6.9/6.54

HIS0800

6.5/6.77

6.4/6.46

6.7/10.77

6.6/6.63

6.6/6.76

6.5/10.66

6.4/6.82
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ATP7A

Folded/Unfolded

ResName

WT

C1002F

D1044E

G666R

ASP0675P

3.52/3.47 3.23/3.53 3.19/3.35 3.52/3.47 3.73/3.35 3.36/3.2

ASP0747P

2.46/2.23 2.75/2.7

ASP0782P

3.37/3.65 3.53/3.35 3.62/3.69 3.46/3.48 3.32/3.91 3.51/3.49 3.7/3.91

ASP0826P

3.38/3.31 3.48/3.13 3.58/3.89 3.43/3.84 3.79/3.93 3.52/3.9

ASP0828P

3.95/4

ASP0838P

3.95/3.98 3.91/3.9

ASP0846P

3.58/3.76 3.72/3.67 3.81/3.71 3.59/3.77 3.68/2.98 3.7/3.71

ASP0859P

1.79/1.5

ASP0870P

3.74/3.54 3.48/3.49 3.66/3.68 3.93/3.53 3.5/3.95

3.41/3.59 3.57/3.95 2.73/2.83

3.89/3.91

ASP0910P

3.51/3.56 3.13/3.39 3.56/3.92 3.64/3.46 3.38/3.78 3.73/3.71 3.75/3.78 3.58/3.47

3.43/3.52

ASP0935P

3.35/3.44 2.66/2.93 2.53/2.32 3.11/3.08 3.28/3.77 3.35/3.08 3.08/3.77 2.23/2.19

2.65/2.57

ASP1044P

2.75/2.4

2.32/2.79

ASP1101P

3.74/3.84 3.73/3.58 3.57/3.67 3.44/3.53 3.64/3.74 3.76/3.76 3.67/3.74 3.85/3.84

3.7/3.7

ASP1110P

3.4/3.31

3.3/3.67

ASP1139P

3.34/3.84 3.7/3.69

ASP1151P

3.65/3.72 3.44/3.49 3.81/3.41 2.88/3.69 3.75/3.88 3.81/3.94 3.8/3.88

3.83/3.85

3.54/3.84

ASP1166P

3.81/3.82 3.81/3.85 3.49/3.59 3.48/3.78 3.56/4.26 3.71/3.46 3.75/4.26 3.82/3.76

3.93/3.84

ASP1198P

3.78/3.42 3.76/3.78 3.64/3.72 3.75/3.7

ASP1201P

3.74/3.71 3.76/3.76 3.6/2.16

ASP1219P

3.65/3.47 3.34/3.44 2.05/3.59 3.18/3.93 2.33/3.82 3.53/3.35 2.59/3.82 3.52/3.5

3.19/3.71

ASP1220P

3.04/2.7

3.35/3.62 3.58/2.69 3.97/2.96 3.95/3.77 2.97/3.41 2.99/3.77 3.33/3.35

3.13/3.4

ASP1230P

2.87/3.2

2.93/3.31 2.66/3.25 2.46/3.17 1.97/3.96 2.51/2.27 2.72/3.96 2.19/2.24

3.01/3.05

ASP1256P

2.72/2.62 2.97/2.94 3.61/3.62 2.98/2.68 2.53/3.67 3.05/2.81 2.72/3.67 2.82/2.92

3.01/2.99

ASP1301P

3.52/3.33 3.38/3.52 3.61/2.66 3.36/3.01 3.95/3.83 3.43/3.41 3.49/3.83 3.15/3.19

3.02/3.01

ASP1305P

2.42/2.65 2.89/2.65 2.74/3.31 2.55/3.56 2.3/3.56

2.11/1.98

2.99/2.68 2.91/3.1

3.94/3.99 3.98/3.96 4.1/3.96

I1264V

K742R

M1311V

R844C

S653Y

3.65/3.35 undet/3.55 3.54/3.47

3.07/3.78 3.18/2.81 3.15/3.78 2.52/2.28
3.55/3.62

2.58/2.7
3.75/3.77

3.89/3.93 3.01/3.05

4/3.23

3.86/3.98 3.93/3.96 3.57/3.98 3.79/3.73

3.99/4

3.95/3.84 3.87/3.95 3.95/4.11 3.82/3.94 3.93/4.11 3.93/3.91

3.97/3.88

3.74/2.98 3.84/3.85

3.77/3.69

2.31/2.37 3.15/2.71 2.05/2.72 2.64/3.28 2.78/2.51 2.55/3.28 2.51/2.19

2.44/2.45

2.45/2.46 1.56/3.66 2.55/3.57 2.69/3.54 3.14/3.25 2.34/3.54 2.51/2.49

3.57/3.55 3.66/3

3.7/3.53

3.22/3.8

3.13/3.2

3.36/3.8

3.49/3.55

3.75/3.65 3.67/3.48 3.58/3.86 3.78/3.85 3.39/3.86 3.73/3.7

3.77/3.57

3.47/3.98 3.72/3.6

3.57/3.98 3.62/3.57

3.37/3.63

3.65/3.15 3.62/3.82 3.7/3.72

3.69/3.82 3.77/3.69

3.7/3.81
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2.46/2.23 2.74/3.55 2.46/1.94

ASP1323P

3.73/3.79 3.74/3.78 3.53/3.47 3.58/3.41 3.73/3.76 3.6/3.58

ASP1330P

2.71/2.8

3.5/3.57

3.56/3.55

2.88/2.79

3.41/3.49

ASP1337P

3.57/3.65 3.46/3.44 3.17/2.91 3.18/3.54 2.89/3.93 3.26/3.49 3.21/3.93 3.51/3.56

3.18/3.49

ASP1340P

2.71/2.98 2.31/2.43 2.94/2.71 3.67/2.7

3.47/3.41

ASP1346P

2.38/2.39 2.54/2.84 2.8/3.49

2.67/2.38 3.56/3.16 3.46/3.68 3.44/3.8

3.05/3.7

3.6/3.76

3.29/3.24 2.65/3.8

3.67/3.84 2.66/3.7

2.9/3.09

2.46/3.54 2.63/3.85 2.78/2.85 2.78/3.85 2.47/2.53

2.33/2.47

3.56/3.84 3.78/4

3.72/3.73

3.21/3.56

3.75/3.81 3.74/3.98 3.28/3.14

3.95/3.95

GLU0691P 3.83/3.96 3.75/4.01 2.18/3.44 3.75/2.72 3.75/3.99 2.78/3.69 3.94/3.99 3.88/3.95

3.77/3.94

GLU0702P 3.83/3.49 3.8/3.96

3.46/4.01 3.71/3.66

3.43/3.48

3.42/3.48 3.26/3.03 3.62/2.69 2.86/3.65 3.12/2.76 3.42/3.65 3.45/3.64

3.23/3.05

GLU0798P 3.23/3.15 2.56/2.93 2.49/3.93 2.89/3.24 3.02/3.74 2.41/3.14 3.38/3.74 2.61/2.63

3.07/2.49

GLU0807P 3.71/3.83 4.01/3.93 4.14/4.01 3.84/4.02 3.24/3.81 4.05/3.92 3.95/3.81 2.84/3.13

3.69/3.29

GLU0819P 4.09/4.02 4.04/3.94 3.95/3.69 4.01/3.44 4.09/4.51 3.9/3.85

3.98/4.51 4.14/4.11

3.87/3.69

GLU0834P 3.47/3.52 3.26/3.45 3.52/4.13 3.12/4.04 2.97/3.94 3.06/3.48 3.27/3.94 3.49/3.47

3.29/3.21

GLU0835P 4.11/4.2

4.32/4.1

GLU0646P 3.37/2.39 3.83/3.66 3.9/3.87

GLU0690P 3.73/3.86 3.59/3.81 3.97/2.22 3.65/3.91 3.9/3.98

GLU0771P 3/3.46

3.13/2.72 3.72/4

3.77/3.05 1.53/3.15 3.85/4.01 3.71/3.8

4.24/4.13 4.27/4.16 4.28/3.97 4.07/4.15 4.24/4.06 4.13/4.15 4.07/4.09

GLU0840P 4.06/4.05 4.02/4.04 4.01/3.74 4.02/3.74 3.94/4.01 3.96/4.08 4.01/4.01 4/3.98

3.98/3.98

GLU0864P 3.64/3.74 3.52/3.78 3.64/3.03 3.8/2.96

3.82/3.66

3.54/3.94 3.81/3.82 3.48/3.94 3.55/3.64

GLU0871P 3.33/2.81 3.17/3.23 2.92/4.06 2.83/3.76 3.3/3.81

3.34/3.43 3.45/3.81 3.67/3.86

3.49/3.46

GLU0877P 3.53/3.75 3.78/3.73 3.95/3.95 3.19/3.86 3.59/3.76 3.54/3.61 3.66/3.76 3.38/3.16

3.88/3.94

GLU0921P 3.76/3.76 3.8/3.91

3.75/3.13

3.57/3.55 3.32/4

3.74/3.73 3.97/4.02 3.45/3.73 3.72/3.87

GLU0922P 3.81/3.84 2.84/3.76 3.73/3.96 3.57/3.87 3.38/3.49 3.54/2.96 3.65/3.49 3.87/3.24

3.8/3.93

GLU0965P 3.26/4

2.69/2.77

4/3.78

4.15/3.96 3.87/4

2.75/3.97 4.01/3.73 1.99/3.97 4.01/3.88

GLU0968P 3.97/4.02 4.02/3.99 3.97/3.72 3.82/2.84 3.97/4.01 4/4.01
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4.03/3.98

GLU0982P 3.76/3.14 3.54/3.51 3.7/3.14
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2.88/2.77 3.02/3.77 3.52/3.54

3.69/3.82

GLU1030P 3.06/2.7
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3.03/3.3

GLU1033P 3.1/2.99

3.05/3.08 2.23/2.1

2.83/2.93

3.03/2.39 2.94/3.83 3.12/3.1

3.23/3.83 2.76/2.78

GLU1064P 3.56/3.72 3.54/3.82 3.73/3.72 3.76/3.72 3.11/3.87 3.91/3.88 3.58/3.87 3.81/3.9

3.87/3.48

GLU1081P 2.27/3.29 2.85/3.18 3.5/3.49
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3.33/3.34 2.63/4.01 3.39/3.53 3.47/4.01 3.47/3.46
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3.84/3.85

GLU1099P 3.85/3.79 3.56/3.67 3.85/4

3.97/3.97 3.97/3.23 3.96/3.97 3.93/3.23 3.56/3.58

3.87/3.98

GLU1103P 3.84/3.73 3.3/3.86

3.3/2.64

3.57/3.16 2.97/3.92 3.13/3.86 3.27/3.92 3.81/3.75

3.54/2.65

GLU1127P 3.16/3.73 3.86/3.6

3.84/3.87 3.99/3.83 3.84/3.87 3.73/3.67 3.83/3.87 3.79/3.72

2.75/3.64

GLU1138P 3.77/3.93 3.74/3.71 3.78/3.97 4/3.94
GLU1155P 3.74/3.85 4.01/4
GLU1186P 3.4/2.45

3.74/3.95 3.99/4.04 3.98/3.95 3.82/3.78

3.82/3.94

3.96/3.85 3.75/3.66 4.07/4.01 3.96/3.68 3.02/4.01 3.69/3.85

4.04/3.97

2.25/3.19 2.98/2.8

2.36/2.85 2.48/3.84 3.41/3.15 3.46/3.84 3.54/3.43

3.49/3.47

GLU1205P 3.52/3.42 3.27/3.22 2.86/2.93 3.23/3.03 2.98/3.22 2.98/3.18 3.25/3.22 3.05/2.79

3.47/3.06

GLU1207P 2.73/2.68 3.07/3.38 2.93/3.49 2.5/2.46

3.34/3.47 3.12/3.46 3.22/3.47 2.74/3.33

3.39/3.41

2.94/3.54 4.07/4.07 3.15/3.55 4.06/3.71 4.09/3.55 4.11/4.12

3.53/3.68

GLU1221P 2.91/3.67 4.12/4.1

GLU1235P 3.92/3.82 3.49/3.38 2.58/2.48 3.52/3.4
GLU1237P 3.92/3.92 3.59/3.76 3.8/3.93

3.81/4.04 3.59/3.56 3.83/4.04 3.53/3.61

3.77/3.83 3.78/4

3.85/3.67 3.56/4

3.75/3.75

3.54/3.74
3.78/3.84

GLU1249P 2.35/3.11 2.89/2.74 2.98/2.62 3.04/2.99 3.15/3.32 3.15/2.85 3.66/3.32 2.52/2.8

2.86/2.72

GLU1276P 3.42/3.52 3.51/3.58 3.61/3.6

3.48/3.55

3.49/3.57 3.46/3.96 3.6/3.67

3.36/3.96 3.34/3.08

GLU1291P 3.73/3.79 3.88/3.92 3.51/3.49 4.02/3.21 3.34/3.95 3.68/3.78 3.89/3.95 3.3/3.55

3.42/3.02

GLU1292P 3.55/3.81 3.93/3.8

3.56/3.72

3.94/3.63 3.97/3.82 3.83/3.77 3.77/3.6

GLU1327P 3.53/2.95 3.72/3.63 3.52/3.77 3.18/3.51 3.7/3.7
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3.82/3.77 3.55/3.94

3.09/2.92 3.36/3.7

4/4
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6.29/6.48
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HIS0682P

5.54/5.97 6.46/6.56 6.46/6.33 6.42/6.5

6.46/6.48

HIS0683P

6.49/6.46 6.51/6.28 6.04/6.17 6.34/6.54 6.04/6.54 6.49/6.45 6.2/6.54

HIS0696P

6.64/6.51 6.45/6.52 6.57/6.55 6.67/6.51 6.66/6.47 6.66/6.5
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HIS1036P
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5.75/5.37
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6.55/6.65
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6.49/6.48 5.95/6.45 6.56/6.54 6.65/6.68 6.61/6.46 6.74/6.53 6.52/6.46 6.35/6.26

6.48/6.24

HIS1206P
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6.16/6.02

HIS1241P

6.49/6.51 6.5/6.54

6.28/6.46

HIS1281P

6.12/5.52 5.83/6.11 6.22/6.26 5.76/6.45 6.05/6.47 6.33/6.29 6.05/6.47 5.36/5.98
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